Trane Technologies (TT) 10-Q 5 May 20 2020 Q1 Quarterly report Financial data

Cover Cover

Cover Cover - shares	3 Months Ended
	Mar. 31, 2020	Apr. 17, 2020
Document and Entity Information [Abstract]
Entity File Number	001-34400
Entity Interactive Data Current	Yes
Title of 12(b) Security	Ordinary Shares, Par Value $1.00 per Share
Entity Address, Address Line One	170/175 Lakeview Dr.
Entity Incorporation, State or Country Code	L2
Document Transition Report	false
Document Quarterly Report	true
Entity Registrant Name	TRANE TECHNOLOGIES PLC
Entity Central Index Key	0001466258
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		239,207,928
Entity Current Reporting Status	Yes
Entity Small Business	false
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Tax Identification Number	98-0626632
Entity Address, Address Line Two	Airside Business Park
Entity Address, City or Town	Swords Co. Dublin
Entity Address, Country	IE
City Area Code	353
Local Phone Number	18707400
Trading Symbol	TT
Security Exchange Name	NYSE
Entity Address, Postal Zip Code	00000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net revenues	$ 2,641.3	$ 2,803.7
Cost of goods sold	(1,898.8)	(1,989.2)
Selling and administrative expenses	(588.1)	(578)
Operating income	154.4	236.5
Interest expense	(63.1)	(51)
Other income/(expense), net	12.5	(18)
Earnings before income taxes	103.8	167.5
Benefit (provision) for income taxes	(51)	(20.2)
Earnings from continuing operations	52.8	147.3
Discontinued operations, net of tax	(78.7)	56.4
Net earnings (loss)	(25.9)	203.7
Less: Net earnings from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest	(2.8)	(3.1)
Less: Net earnings from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest	(0.5)	(0.7)
Net earnings (loss) attributable to Trane Technologies plc	(29.2)	199.9
Amounts attributable to Trane Technologies plc ordinary shareholders:
Continuing operations	50	144.2
Discontinued operations	(79.2)	55.7
Net earnings (loss) attributable to Trane Technologies plc	$ (29.2)	$ 199.9
Basic:
Continuing operations	$ 0.21	$ 0.59
Discontinued operations	(0.33)	0.23
Net earnings (loss)	(0.12)	0.82
Diluted:
Continuing operations	0.21	0.59
Discontinued operations	(0.33)	0.23
Net earnings (loss)	$ (0.12)	$ 0.82
Weighted-average shares outstanding
Basic	239.5	242.5
Diluted	242.3	245.2
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$ (48)	$ (2)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0.3	(1.4)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax	0.3	0.1
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax	(0.2)	(0.5)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax	0.4	(1.8)
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax	(21.3)	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax	11.5	12.9
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax	(3.6)	1.7
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansCurrencyTranslationBeforeTax	5.2	(1.4)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	(2.8)	(3.5)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent	(11)	9.7
Other comprehensive income (loss)	(58.6)	5.9
Comprehensive income (loss), net of tax	(84.5)	209.6
Less: Comprehensive income (loss) attributable to noncontrolling interests	(3.4)	(4.2)
Comprehensive income (loss) attributable to Trane Technologies plc	$ (87.9)	$ 205.4

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 2,647.7	$ 1,278.6
Accounts and notes receivable, net	2,091.8	2,184.6
Inventories	1,463.7	1,278.6
Other current assets	356.6	344.8
Disposal Group, Including Discontinued Operation, Assets	0	4,207.2
Total current assets	6,559.8	9,293.8
Property, plant and equipment, net	1,326.2	1,352
Goodwill	5,082.3	5,125.7
Intangible assets, net	3,289	3,323.6
Other noncurrent assets	1,378.3	1,397.2
Total assets	17,635.6	20,492.3
LIABILITIES AND EQUITY
Accounts payable	1,446.7	1,381.3
Accrued compensation and benefits	316	442.4
Accrued expenses and other current liabilities	1,528.4	1,564.2
Short-term borrowings and current maturities of long-term debt	949.7	650.3
Disposal Group, Including Discontinued Operation, Liabilities	0	1,200.4
Total current liabilities	4,240.8	5,238.6
Long-term debt	4,624.8	4,922.9
Postemployment and other benefit liabilities	1,008.2	1,048.2
Deferred and noncurrent income taxes	561.2	572
Other noncurrent liabilities	1,410.8	1,398.2
Total liabilities	11,845.8	13,179.9
Equity:
Ordinary shares	263.7	262.8
Treasury Stock, Value	(1,719.4)	(1,719.4)
Capital in excess of par value	26.4	0
Retained earnings	8,127.9	9,730.8
Accumulated other comprehensive income (loss)	(926)	(1,006.6)
Total Trane Technologies plc shareholders’ equity	5,772.6	7,267.6
Noncontrolling interests	17.2	44.8
Total equity	5,789.8	7,312.4
Total liabilities and equity	$ 17,635.6	$ 20,492.3

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Ordinary shares	Ordinary shares held in treasury, at cost	Capital in excess of par value	Retained earnings	Accumulated other comprehensive income (loss)	Noncontrolling Interests
Beginning balance at Dec. 31, 2018	$ 7,064.8	$ 266.4	$ (1,719.4)	$ 0	$ 9,439.8	$ (964.1)	$ 42.1
Beginning balance (shares) at Dec. 31, 2018		266.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	203.7				199.9		3.8
Other comprehensive income (loss)	5.9					5.5	0.4
Shares issued under incentive stock plans	6.3	$ 1.5		4.8
Shares issued under incentive stock plans (shares)		1.5
Repurchase of ordinary shares	(250)	$ (2.4)		(34.6)	(213)
Repurchase of ordinary shares (shares)		(2.4)
Share-based compensation	29			29.7	(0.7)
Dividends declared to noncontrolling interest	(9.3)						(9.3)
Cash dividends declared	127.7				127.7
Other	0.1			0.1
Ending balance (shares) at Mar. 31, 2019		265.5
Ending balance at Mar. 31, 2019	6,922.8	$ 265.5	(1,719.4)	0	9,298.3	(958.6)	37
Beginning balance at Dec. 31, 2019	7,312.4	$ 262.8	$ (1,719.4)	0	9,730.8	(1,006.6)	44.8
Beginning balance (shares) at Dec. 31, 2019		262.8	24.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	(25.9)				(29.2)		3.3
Other comprehensive income (loss)	(58.6)					(58.7)	0.1
Shares issued under incentive stock plans		$ 0.9
Shares issued under incentive stock plans (shares)		0.9
Stock Issued During Period, Value, Stock Options Exercised, net of tax remittances	(5.6)			(6.5)
Share-based compensation	27.6			29	(1.4)
Dividends declared to noncontrolling interest	(6.1)						(6.1)
Investment by JV Partner	(7)			(3.9)			3.1
Cash dividends declared	126.7				126.7
Distribution of Industrial Businesses	(1,334.3)				(1,445.6)	139.3	(28)
Ending balance (shares) at Mar. 31, 2020		263.7	24.5
Ending balance at Mar. 31, 2020	$ 5,789.8	$ 263.7	$ (1,719.4)	$ 26.4	$ 8,127.9	$ (926)	$ 17.2

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net earnings	$ (25.9)	$ 203.7
Discontinued operations, net of tax	78.7	(56.4)
Adjustments for non-cash transactions:
Depreciation and amortization	75	70.9
Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash	17.1	25.8
Stock settled share-based compensation	29	29.7
Changes in assets and liabilities, net of the effects of acquisitions	(295.8)	(266.2)
Other non-cash items, net	(7.4)	4.9
Net cash provided by (used in) continuing operating activities	(129.3)	12.4
Net cash provided by (used in) discontinued operating activities	(198.3)	(65)
Net cash provided by (used in) operating activities	(327.6)	(52.6)
Cash flows from investing activities:
Capital expenditures	(34.7)	(49)
Acquisitions of businesses, net of cash acquired		22
Cash Acquired in Excess of Payments to Acquire Business	1
Other investing activities, net	0	1.3
Net cash provided by (used in) continuing investing activities	(33.7)	(69.7)
Net cash provided by (used in) discontinued investing activities	(6.8)	(6.7)
Net cash provided by (used in) investing activities	(40.5)	(76.4)
Cash flows from financing activities:
Short-term borrowings (payments), net	0	23.9
Proceeds from long-term debt	0	1,497.9
Net proceeds from (payments of) debt	0	1,521.8
Debt issuance costs	0	10.6
Dividends paid to ordinary shareholders	(125.9)	(127.7)
Dividends paid to noncontrolling interests	(6.1)	(9.3)
Proceeds from shares issued under incentive plans	(5.6)	(6.3)
Repurchase of ordinary shares	0	(250)
Receipt of a one-time special cash payment	1,900	0
Other financing, net	7	0
Net cash provided by (used in) continuing financing activities	1,769.4	1,130.5
Net cash provided by (used in) discontinued financing activities	0	(0.4)
Net cash provided by (used in) financing activities	1,769.4	1,130.1
Effect of exchange rate changes on cash and cash equivalents	(32.2)	2.9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	1,369.1	1,004
Cash and cash equivalents - beginning of period	1,278.6	878.4
Cash and cash equivalents - end of period	$ 2,647.7	$ 1,882.4

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Trane Technologies plc (formerly known as Ingersoll Rand plc), a public limited company incorporated in Ireland in 2009, and its consolidated subsidiaries (collectively, the Company), is a global climate innovator that brings efficient and sustainable climate solutions to buildings, homes and transportation driven by strategic brands Trane ® and Thermo King ® and an environmentally responsible portfolio of products and services. The accompanying unaudited Condensed Consolidated Financial Statements of Trane Technologies plc reflects the consolidated operations of the Company and have been prepared in accordance with United States Securities and Exchange Commission (SEC) interim reporting requirements. Accordingly, the accompanying Condensed Consolidated Financial Statements do not include all disclosures required by accounting principles generally accepted in the United States of America (GAAP) for full financial statements and should be read in conjunction with the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 . In the opinion of management, the accompanying Condensed Consolidated Financial Statements contain all adjustments, which include only normal recurring adjustments, necessary to fairly state the condensed consolidated results for the interim periods presented. Reportable Segments Prior to the separation of the Company's Industrial segment on February 29, 2020, the Company announced a new organizational model and business segment structure designed to enhance its regional go-to-market capabilities, aligning the structure with the Company's strategy and increased focus on climate innovation. Under the revised structure, the Company created three new regional operating segments from the former climate segment, which also serve as the Company's reportable segments. • The Company's Americas segment innovates for customers in the North America and Latin America regions. The Americas segment encompasses commercial heating and cooling systems, building controls, and energy services and solutions; residential heating and cooling; and transport refrigeration systems and solutions. • The Company's EMEA segment innovates for customers in the Europe, Middle East and Africa region. The EMEA segment encompasses heating and cooling systems, services and solutions for commercial buildings, and transport refrigeration systems and solutions. • The Company's Asia Pacific segment innovates for customers throughout the Asia Pacific region and India. The Asia Pacific segment encompasses heating and cooling systems, services and solutions for commercial buildings and transport refrigeration systems and solutions. This model is designed to create deep customer focus and relevance in markets around the world. Each segment reports through separate management teams and regularly reviews their operating results with the Chief Executive Officer, the Company's Chief Operating Decision Maker (CODM) determined in accordance with applicable accounting guidance. All prior period comparative segment information has been recast to reflect the current reportable segments.

Completion of Reverse Morris Tr

Completion of Reverse Morris Trust Transaction (Notes)	3 Months Ended
	Mar. 31, 2020
Completion of Reverse Morris Trust Transaction [Abstract]
Completion of Reverse Morris Trust Transaction [Text Block]	Completion of Reverse Morris Trust Transaction On February 29, 2020 (Distribution Date), the Company completed its Reverse Morris Trust transaction (the Transaction) with Gardner Denver Holdings, Inc. (Gardner Denver) whereby the Company separated its former Industrial segment (Ingersoll Rand Industrial) through a pro rata distribution to shareholders of record as of February 24, 2020. Ingersoll Rand Industrial then merged into a wholly-owned subsidiary of Gardner Denver, which changed its name to Ingersoll-Rand Inc. Upon close of the Transaction, the Company’s existing shareholders received 50.1% of the shares of Gardner Denver common stock on a fully-diluted basis and Gardner Denver stockholders retained 49.9% of the shares of Gardner Denver on a fully diluted basis. As a result, the Company’s shareholders received .8824 shares of Gardner Denver common stock with respect to each share owned as of February 24, 2020. In connection with the Transaction, Ingersoll-Rand Services Company, an affiliate of Ingersoll Rand Industrial, borrowed an aggregate principal amount of $1.9 billion under a senior secured first lien term loan facility (Term Loan), the proceeds of which were used to make a special cash payment of $1.9 billion to a subsidiary of the Company. The obligations under the Term Loan were retained by Ingersoll-Rand Services Company, which following the Transaction is a wholly-owned subsidiary of Gardner Denver. Discontinued Operations After the Distribution Date, the Company does not beneficially own any Ingersoll Rand Industrial shares of common stock and will no longer consolidate Ingersoll Rand Industrial in its financial statements. In accordance with GAAP, the historical results of Ingersoll Rand Industrial are presented as a discontinued operation in the Condensed Consolidated Statement of Comprehensive Income and Condensed Consolidated Statement of Cash Flows. In addition, the assets and liabilities of Ingersoll Rand Industrial have been recast to held-for-sale at December 31, 2019. In connection with the Transaction, the Company entered into several agreements with Gardner Denver covering supply, administrative and tax matters to provide or obtain services on a transitional basis for varying periods after the Distribution Date. The agreements cover services such as manufacturing, information technology, human resources and finance. Income and expenses under these agreements are not expected to be material. In addition, the Company expects to pay Gardner Denver in order to meet minimum funding requirements for certain pensions, postretirement benefits other than pensions and deferred compensation plan liabilities as required by the employee matter agreement. Furthermore, in accordance with the merger agreement, within ninety days of the Distribution Date, the Company will provide the final working capital adjustment to Gardner Denver.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Accounting Pronouncements	Recent Accounting Pronouncements The Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) is the sole source of authoritative GAAP other than SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an Accounting Standards Update (ASU) to communicate changes to the codification. The Company considers the applicability and impact of all ASU's. ASU's not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Condensed Consolidated Financial Statements. Recently Adopted Accounting Pronouncements In August 2018, the FASB issued ASU 2018-15, "Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract" (ASU 2018-15), which aligns the requirements for capitalizing implementation costs in a cloud-computing arrangement service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. In addition, the guidance also clarifies the presentation requirements for reporting such costs in the financial statements. ASU 2018-15 is effective for annual reporting periods beginning after December 15, 2019 with early adoption permitted. The Company adopted this standard on January 1, 2020 on a prospective basis with no material impact on its financial statements. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses” (ASU 2016-13) which changes the impairment model for most financial assets and certain other instruments from an incurred loss model to an expected loss model. In addition, the guidance also requires incremental disclosures regarding allowances and credit quality indicators. ASU 2016-13 is required to be adopted using the modified-retrospective approach and is effective in fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted. The Company adopted this standard on January 1, 2020 with no material impact on its financial statements. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" (ASU 2019-12), which simplifies certain aspects of income tax accounting guidance in ASC 740, reducing the complexity of its application. Certain exceptions to ASC 740 presented within the ASU include: intraperiod tax allocation, deferred tax liabilities related to outside basis differences, year-to-date loss in interim periods, among others. ASU 2019-12 is effective for annual reporting periods beginning after December 15, 2020 including interim periods therein with early adoption permitted. The Company is currently assessing the impact of the ASU on its financial statements.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2020
Inventory, Net [Abstract]
Inventories	Inventories Depending on the business, U.S. inventories are stated at the lower of cost or market using the last-in, first-out (LIFO) method or the lower of cost or market using the first-in, first-out (FIFO) method. Non-U.S. inventories are primarily stated at the lower of cost or market using the FIFO method. The major classes of inventory were as follows: In millions March 31, December 31, Raw materials $ 348.8 $ 333.5 Work-in-process 173.8 173.7 Finished goods 973.4 804.9 1,496.0 1,312.1 LIFO reserve (32.3 ) (33.5 ) Total $ 1,463.7 $ 1,278.6 The Company performs periodic assessments to determine the existence of obsolete, slow-moving and non-saleable inventories and records necessary provisions to reduce such inventories to net realizable value. Reserve balances, primarily related to obsolete and slow-moving inventories, were $ 67.6 million and $ 66.1 million at March 31, 2020 and December 31, 2019 , respectively.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2020
Goodwill Abstract
Goodwill	Goodwill The Company records goodwill as the excess of the purchase price over the fair value of the net assets acquired in a business combination. Measurement period adjustments may be recorded once a final valuation has been performed. Goodwill is tested and reviewed annually for impairment during the fourth quarter or whenever there is a significant change in events or circumstances that indicate that the fair value of the reporting unit may be less than its carrying value. In connection with the new organizational model and business segment structure, the Company performed a goodwill impairment assessment immediately prior to the reorganization becoming effective, the results of which did not indicate any goodwill impairment. The Company then reassigned its goodwill between the newly designated reporting units using a relative fair value approach. Subsequent to the reassignment, the Company performed a second goodwill impairment assessment under the new reporting structure, the results of which also did not indicate any goodwill impairment. The reassigned amounts of goodwill as of December 31, 2019 and the changes in the carrying amount of goodwill for the three months ended March 31, 2020 were as follows: In millions Americas EMEA Asia Pacific Total Net balance as of December 31, 2019 $ 3,858.8 $ 731.1 $ 535.8 $ 5,125.7 Currency translation (12.1 ) (24.3 ) (7.0 ) (43.4 ) Net balance as of March 31, 2020 $ 3,846.7 $ 706.8 $ 528.8 $ 5,082.3 The net goodwill balances at March 31, 2020 and December 31, 2019 include $ 2,496.0 million of accumulated impairment. The accumulated impairment relates entirely to a charge recorded in 2008.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2020
Intangible Assets Abstract
Intangible Assets	Intangible Assets Indefinite-lived intangible assets are tested and reviewed annually for impairment during the fourth quarter or whenever there is a significant change in events or circumstances that indicate that the fair value of the asset may be less than the carrying amount of the asset. All other intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives. The gross amount of the Company’s intangible assets and related accumulated amortization were as follows: March 31, 2020 December 31, 2019 In millions Gross carrying amount Accumulated amortization Net carrying amount Gross carrying amount Accumulated amortization Net carrying amount Customer relationships $ 1,919.6 $ (1,262.9 ) $ 656.7 $ 1,928.5 $ (1,239.2 ) $ 689.3 Patents 164.4 (162.8 ) 1.6 171.8 (169.7 ) 2.1 Other 40.3 (34.3 ) 6.0 40.4 (33.7 ) 6.7 Total finite-lived intangible assets 2,124.3 (1,460.0 ) 664.3 2,140.7 (1,442.6 ) 698.1 Trademarks (indefinite-lived) 2,624.7 — 2,624.7 2,625.5 — 2,625.5 Total $ 4,749.0 $ (1,460.0 ) $ 3,289.0 $ 4,766.2 $ (1,442.6 ) $ 3,323.6 Intangible asset amortization expense was $30.3 million and $29.1 million for the three months ended March 31, 2020 and 2019 , respectively.

Debt and Credit Facilities

Debt and Credit Facilities	3 Months Ended
	Mar. 31, 2020
Debt Credit Facilities
Debt and Credit Facilities	Debt and Credit Facilities Short-term borrowings and current maturities of long-term debt consisted of the following: In millions March 31, December 31, Debentures with put feature $ 343.0 $ 343.0 2.625% Senior notes due 2020 (1) 299.9 299.8 2.900% Senior notes due 2021 (2) 299.3 — Other current maturities of long-term debt 7.5 7.5 Total $ 949.7 $ 650.3 (1) The 2.625% Senior notes due in May 2020 were redeemed in April 2020. (2) The 2.900% Senior notes are due in February 2021. Commercial Paper Program The Company uses borrowings under its commercial paper program for general corporate purposes. The maximum aggregate amount of unsecured commercial paper notes available to be issued, on a private placement basis, under the commercial paper program is $ 2.0 billion . The Company had no outstanding balance under its commercial paper program as of March 31, 2020 and December 31, 2019 . Debentures with Put Feature At March 31, 2020 and December 31, 2019 , the Company had $343.0 million of fixed rate debentures outstanding which contain a put feature that the holders may exercise on each anniversary of the issuance date. If exercised, the Company is obligated to repay in whole or in part, at the holder’s option, the outstanding principal amount of the debentures plus accrued interest. If these options are not exercised, the final contractual maturity dates would range between 2027 and 2028 . Holders of these debentures had the option to exercise the put feature on $37.2 million of the outstanding debentures in February 2020, subject to the notice requirement. No exercises were made. Long-term debt , excluding current maturities, consisted of the following: In millions March 31, December 31, 2.900% Senior notes due 2021 (1) — 299.1 9.000% Debentures due 2021 124.9 124.9 4.250% Senior notes due 2023 697.9 697.8 7.200% Debentures due 2020-2025 37.3 37.3 3.550% Senior notes due 2024 496.8 496.6 6.480% Debentures due 2025 149.7 149.7 3.500% Senior notes due 2026 396.9 396.8 3.750% Senior notes due 2028 545.2 545.1 3.800% Senior notes due 2029 743.7 743.6 5.750% Senior notes due 2043 494.6 494.5 4.650% Senior notes due 2044 296.0 295.9 4.300% Senior notes due 2048 296.0 296.0 4.500% Senior notes due 2049 345.5 345.5 Other loans and notes 0.3 0.1 Total $ 4,624.8 $ 4,922.9 (1) The 2.900% Senior notes are due in February 2021. Issuance of Senior Notes In March 2019, the Company issued $1.5 billion principal amount of senior notes in three tranches through Trane Technologies Luxembourg Finance S.A., an indirect, wholly-owned subsidiary. The tranches consist of $400 million aggregate principal amount of 3.500% senior notes due 2026, $750 million aggregate principal amount of 3.800% senior notes due 2029 and $350 million aggregate principal amount of 4.500% senior notes due 2049. The notes are fully and unconditionally guaranteed by each of Trane Technologies plc, Ingersoll-Rand Global Holding Company Limited, Trane Technologies Lux International Holding Company S.à.r.l, Trane Technologies Irish Holdings Unlimited Company, and Trane Technologies Company LLC. The Company has the option to redeem the notes in whole or in part at any time, prior to their stated maturity date at redemption prices set forth in the indenture agreement. The notes are subject to certain customary covenants, however, none of these covenants are considered restrictive to the Company’s operations. Other Credit Facilities The Company maintains two 5-year, $ 1.0 billion revolving credit facilities (the Facilities) through its wholly-owned subsidiaries, Ingersoll-Rand Global Holding Company Limited and Trane Technologies Luxembourg Finance S.A. (collectively, the Borrowers). Each senior unsecured credit facility, one of which matures in March 2021 and the other in April 2023, provides support for the Company's commercial paper program and can be used for working capital and other general corporate purposes. Trane Technologies plc, Trane Technologies Irish Holdings Unlimited Company, Trane Technologies Lux International Holding Company S.à.r.l. and Trane Technologies Company LLC each provide irrevocable and unconditional guarantees for these Facilities. In addition, each Borrower will guarantee the obligations under the Facilities of the other Borrower. Total commitments of $ 2.0 billion were unused at March 31, 2020 and December 31, 2019 . Fair Value of Debt The carrying value of the Company's short-term borrowings is a reasonable estimate of fair value due to the short-term nature of the instruments. The fair value of the Company's debt instruments at March 31, 2020 and December 31, 2019 was $5.9 billion and $6.2 billion , respectively. The Company measures the fair value of its long-term debt instruments for disclosure purposes based upon observable market prices quoted on public exchanges for similar assets. These fair value inputs are considered Level 2 within the fair value hierarchy. The methodologies used by the Company to determine the fair value of its long-term debt instruments at March 31, 2020 are the same as those used at December 31, 2019

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2020
Financial Instruments Abstract
Financial Instruments	Financial Instruments In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. These fluctuations can increase the cost of financing, investing and operating the business. The Company may use various financial instruments, including derivative instruments, to manage the risks associated with interest rate, commodity price and foreign currency exposures. These financial instruments are not used for trading or speculative purposes. The Company recognizes all derivatives on the Condensed Consolidated Balance Sheet at their fair value as either assets or liabilities. On the date a derivative contract is entered into, the Company designates the derivative instrument as a cash flow hedge of a forecasted transaction or as an undesignated derivative. The Company formally documents its hedge relationships, including identification of the derivative instruments and the hedged items, as well as its risk management objectives and strategies for undertaking the hedge transaction. This process includes linking derivative instruments that are designated as hedges to specific assets, liabilities or forecasted transactions. The Company assesses at inception and at least quarterly thereafter, whether the derivatives used in cash flow hedging transactions are highly effective in offsetting the changes in the cash flows of the hedged item. To the extent the derivative is deemed to be a highly effective hedge, the fair market value changes of the instrument are recorded to Accumulated other comprehensive income (loss) (AOCI). If the hedging relationship ceases to be highly effective, or it becomes probable that a forecasted transaction is no longer expected to occur, the hedging relationship will be undesignated and any future gains and losses on the derivative instrument will be recorded in Net earnings . The fair values of derivative instruments included within the Condensed Consolidated Balance Sheets were as follows: Derivative assets Derivative liabilities In millions March 31, December 31, March 31, December 31, Derivatives designated as hedges: Currency derivatives $ 0.6 $ 0.1 $ 4.2 $ 3.9 Derivatives not designated as hedges: Currency derivatives 5.8 1.0 1.8 3.3 Total derivatives $ 6.4 $ 1.1 $ 6.0 $ 7.2 Asset and liability derivatives included in the table above are recorded within Other current assets and Accrued expenses and other current liabilities , respectively. Currency Derivative Instruments The notional amount of the Company’s currency derivatives was $ 0.5 billion at both March 31, 2020 and December 31, 2019 . At March 31, 2020 and December 31, 2019 , a net loss of $ 2.7 million and $ 2.9 million , net of tax, respectively, was included in AOCI related to the fair value of the Company’s currency derivatives designated as accounting hedges. The amount expected to be reclassified into Net earnings over the next twelve months is a loss of $ 1.3 million . The actual amounts that will be reclassified to Net earnings may vary from this amount as a result of changes in market conditions. Gains and losses associated with the Company’s currency derivatives not designated as hedges are recorded in Net earnings as changes in fair value occur. At March 31, 2020 , the maximum term of the Company’s currency derivatives was approximately 12 months, except for currency derivatives in place related to a certain long-term contract. Other Derivative Instruments Prior to 2015, the Company utilized forward-starting interest rate swaps and interest rate locks to manage interest rate exposure in periods prior to the anticipated issuance of certain fixed-rate debt. These instruments were designated as cash flow hedges and had a notional amount of $ 1.3 billion . Consequently, when the contracts were settled upon the issuance of the underlying debt, any realized gains or losses in the fair values of the instruments were deferred into AOCI. These deferred gains or losses are subsequently recognized in Interest expense over the term of the related notes. The net unrecognized gain in AOCI was $ 5.8 million at March 31, 2020 and $6.0 million at December 31, 2019 . The net deferred gain at March 31, 2020 will continue to be amortized over the term of notes with maturities ranging from 2023 to 2044. The amount expected to be amortized over the next twelve months is a net gain of $ 0.7 million . The Company has no forward-starting interest rate swaps or interest rate lock contracts outstanding at March 31, 2020 or December 31, 2019 . The following table represents the amounts associated with derivatives designated as hedges affecting Net earnings and AOCI for the three months ended March 31 : Amount of gain (loss) Location of gain (loss) reclassified from Amount of gain (loss) In millions 2020 2019 2020 2019 Currency derivatives designated as hedges $ 0.3 $ (1.4 ) Cost of goods sold $ (0.5 ) $ (0.3 ) Interest rate swaps & locks — — Interest expense 0.2 0.2 Total $ 0.3 $ (1.4 ) $ (0.3 ) $ (0.1 ) The following table represents the amounts associated with derivatives not designated as hedges affecting Other income/(expense), net for the three months ended March 31 : Amount of gain (loss) In millions 2020 2019 Currency derivatives not designated as hedges $ 8.3 $ (3.0 ) Total $ 8.3 $ (3.0 ) The gains and losses associated with the Company’s undesignated currency derivatives are materially offset in Other income/(expense), net by changes in the fair value of the underlying transactions. The following table presents the effects of the Company's designated financial instruments on the associated financial statement line item within the Consolidated Statement of Comprehensive Income where the financial instruments are recorded for the three months ended March 31 : Classification and amount of gain (loss) recognized in income on cash flow hedging relationships 2020 2019 In millions Cost of goods sold Interest expense Cost of goods sold Interest expense Total amounts presented in the Consolidated Statements of Comprehensive Income $ (1,898.8 ) $ (63.1 ) $ (1,989.2 ) $ (51.0 ) Gain (loss) on cash flow hedging relationships Currency derivatives: Amount of gain (loss) reclassified from AOCI and recognized into Net earnings $ (0.5 ) $ — $ (0.3 ) $ — Amount excluded from effectiveness testing recognized in net earnings based on changes in fair value and amortization $ (0.6 ) $ — $ (0.6 ) $ — Interest rate swaps & locks: Amount of gain (loss) reclassified from AOCI and recognized into Net earnings $ — $ 0.2 $ — $ 0.2 Concentration of Credit Risk The counterparties to the Company’s forward contracts consist of a number of investment grade major international financial institutions. The Company could be exposed to losses in the event of nonperformance by the counterparties. However, the credit ratings and the concentration of risk in these financial institutions are monitored on a continuous basis and present no significant credit risk to the Company.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Disclosures [Text Block]	Fair Value Measurements ASC 820, "Fair Value Measurement," (ASC 820) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows: • Level 1: Observable inputs such as quoted prices in active markets; • Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and • Level 3: Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions. ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 : In millions Fair Value Fair value measurements Level 1 Level 2 Level 3 Assets: Derivative instruments $ 6.4 $ — $ 6.4 $ — Liabilities: Derivative instruments $ 6.0 $ — $ 6.0 $ — The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 : In millions Fair Value Fair value measurements Level 1 Level 2 Level 3 Assets: Derivative instruments $ 1.1 $ — $ 1.1 $ — Liabilities: Derivative instruments $ 7.2 $ — $ 7.2 $ — Derivative instruments include forward foreign currency contracts and instruments related to non-functional currency balance sheet exposures. The fair value of the derivative instruments are determined based on a pricing model that uses spot rates and forward prices from actively quoted currency markets that are readily accessible and observable. The carrying values of cash and cash equivalents, accounts receivable, and accounts payable are a reasonable estimate of their fair value due to the short-term nature of these instruments. These methodologies used by the Company to determine the fair value of its financial assets and liabilities at March 31, 2020 are the same as those used at December 31, 2019 . There have been no transfers between levels of the fair value hierarchy.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Leases The Company’s lease portfolio includes various contracts for real estate, vehicles, information technology and other equipment. At contract inception, the Company determines a lease exists if the contract conveys the right to control an identified asset for a period of time in exchange for consideration. Control is considered to exist when the lessee has the right to obtain substantially all of the economic benefits from the use of an identified asset as well as the right to direct the use of that asset. If a contract is considered to be a lease, the Company recognizes a lease liability based on the present value of the future lease payments, with an offsetting entry to recognize a right-of-use asset. Options to extend or terminate a lease are included when it is reasonably certain an option will be exercised. As a majority of the Company’s leases do not provide an implicit rate within the lease, an incremental borrowing rate is used which is based on information available at the commencement date. The following table includes a summary of the Company's lease portfolio and Balance Sheet classification: In millions (except lease term and discount rate) Classification March 31, December 31, Assets Operating lease right-of-use assets (1) Other noncurrent assets $ 453.7 $ 469.4 Liabilities Operating lease current Other current liabilities 143.4 145.0 Operating lease noncurrent Other noncurrent liabilities 315.9 329.9 Weighted average remaining lease term 4.3 years 4.3 years Weighted average discount rate 3.5 % 3.6 % (1) Per ASC 842, prepaid lease payments and lease incentives are recorded as part of the right-of-use asset. The net impact was $5.6 million and $5.5 million at March 31, 2020 and December 31, 2019 , respectively. The Company accounts for each separate lease component of a contract and its associated non-lease component as a single lease component. In addition, the Company utilizes a portfolio approach for the vehicle, information technology and equipment asset classes as the application of the lease model to the portfolio would not differ materially from the application of the lease model to the individual leases within the portfolio. The following table includes lease costs and related cash flow information for the three months ended March 31 : Three months ended In millions 2020 2019 Operating lease expense $ 42.9 $ 38.7 Variable lease expense 6.2 6.4 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases 42.7 38.3 Right-of-use assets obtained in exchange for new operating lease liabilities 43.5 38.5 Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain leases that contain variable lease payments which are based on an index, a rate referenced in the lease or on the actual usage of the leased asset. These payments are not included in the right-to-use asset or lease liability and are expensed as incurred as variable lease expense. Maturities of lease obligations were as follows: In millions March 31, Operating leases: Remaining nine months of 2020 $ 121.1 2021 130.2 2022 93.2 2023 64.3 2024 37.5 After 2024 51.6 Total lease payments $ 497.9 Less: Interest (38.6 ) Present value of lease liabilities $ 459.3

Pensions and Postretirement Ben

Pensions and Postretirement Benefits Other than Pensions	3 Months Ended
	Mar. 31, 2020
Retirement Benefits, Description [Abstract]
Pensions and Postretirement Benefits Other than Pensions	Pensions and Postretirement Benefits Other than Pensions The Company sponsors several U.S. defined benefit and defined contribution plans covering substantially all of the Company's U.S. employees. Additionally, the Company has many non-U.S. defined benefit and defined contribution plans covering eligible non-U.S. employees. Postretirement benefits other than pensions (OPEB) provide healthcare benefits, and in some instances, life insurance benefits for certain eligible employees. Pension Plans The noncontributory defined benefit pension plans covering non-collectively bargained U.S. employees provide benefits on a final average pay formula while plans for most collectively bargained U.S. employees provide benefits on a flat dollar benefit formula or a percentage of pay formula. The non-U.S. pension plans generally provide benefits based on earnings and years of service. The Company also maintains additional other supplemental plans for officers and other key or highly compensated employees. In connection with completion of the Transaction, the Company transferred certain pension obligations for current and former employees of Ingersoll Rand Industrial to Gardner Denver. The transfer of these obligations reduced pension liabilities by $488.7 million , pension assets by $351.3 million and AOCI by $114.2 million . The components of the Company’s net periodic pension benefit cost for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Service cost $ 17.7 $ 18.1 Interest cost 22.5 29.8 Expected return on plan assets (31.9 ) (34.6 ) Net amortization of: Prior service costs 1.3 1.2 Net actuarial (gains) losses 11.3 13.4 Net periodic pension benefit cost $ 20.9 $ 27.9 Net curtailment and settlement (gains) losses (3.6 ) 1.6 Net periodic pension benefit cost after net curtailment and settlement (gains) losses $ 17.3 $ 29.5 Amounts recorded in continuing operations: Operating income $ 14.8 $ 14.3 Other income/(expense), net 0.7 8.3 Amounts recorded in discontinued operations 1.8 6.9 Total $ 17.3 $ 29.5 The Company made contributions to its defined benefit pension plans of $ 50.0 million and $ 18.6 million during the three months ended March 31, 2020 and 2019 , respectively. The current year contribution includes $24.4 million to fund Ingersoll Rand Industrial plans prior to the completion of the Transaction. The Company currently projects that it will contribute approximately $91 million to its enterprise plans worldwide in 2020. Postretirement Benefits Other Than Pensions The Company sponsors several postretirement plans that provide for healthcare benefits, and in some instances, life insurance benefits that cover certain eligible employees. These plans are unfunded and have no plan assets, but are instead funded by the Company on a pay-as-you-go basis in the form of direct benefit payments. Generally, postretirement health benefits are contributory with contributions adjusted annually. Life insurance plans for retirees are primarily noncontributory. In connection with the completion of the Transaction, the Company transferred certain postretirement benefit obligations for current and former employees of Ingersoll Rand Industrial to Gardner Denver. The transfer of these obligations reduced postretirement plan liabilities by $29.8 million and increased AOCI by $4.1 million . The components of net periodic postretirement benefit cost for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Service cost $ 0.6 $ 0.6 Interest cost 2.6 3.9 Net amortization of: Prior service gains — (0.1 ) Net actuarial (gains) losses (1.1 ) (1.6 ) Net periodic postretirement benefit cost $ 2.1 $ 2.8 Amounts recorded in continuing operations: Operating income $ 0.6 $ 0.6 Other income/(expense), net 1.0 1.5 Amounts recorded in discontinued operations 0.5 0.7 Total $ 2.1 $ 2.8

Equity

Equity	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Equity	Equity The authorized share capital of Trane Technologies plc is 1,185,040,000 shares, consisting of (1) 1,175,000,000 ordinary shares, par value $ 1.00 per share, (2) 40,000 ordinary shares, par value EUR 1.00 and (3) 10,000,000 preference shares, par value $ 0.001 per share. There were no Euro-denominated ordinary shares or preference shares outstanding at March 31, 2020 or December 31, 2019 . Changes in ordinary shares and treasury shares for the three months ended March 31, 2020 were as follows: In millions Ordinary shares issued Ordinary shares held in treasury December 31, 2019 262.8 24.5 Shares issued under incentive plans, net 0.9 — March 31, 2020 263.7 24.5 Share repurchases are made from time to time in accordance with management's capital allocation strategy, subject to market conditions and regulatory requirements. Shares acquired and cancelled upon repurchase are accounted for as a reduction of Ordinary Shares and Capital in excess of par value , or Retained earnings to the extent Capital in excess of par value is exhausted. Shares acquired and held in treasury are presented separately on the balance sheet as a reduction to Equity and recognized at cost. In October 2018, the Company's Board of Directors authorized the repurchase of up to $1.5 billion of its ordinary shares under a share repurchase program (2018 Authorization) upon completion of the prior authorized share repurchase program. During the three months ended March 31, 2020 , no amounts were repurchased or cancelled leaving approximately $750 million remaining under the 2018 Authorization at March 31, 2020. Accumulated Other Comprehensive Income (Loss) The changes in Accumulated other comprehensive income (loss) for the three months ended March 31, 2020 was as follows: In millions Derivative Instruments Pension and OPEB Foreign Currency Translation Total Balance at December 31, 2019 $ 5.6 $ (457.4 ) $ (554.8 ) $ (1,006.6 ) Other comprehensive income (loss) before reclassifications 0.3 (19.7 ) (48.1 ) (67.5 ) Amounts reclassified from AOCI 0.3 11.5 — 11.8 Separation of Ingersoll Rand Industrial, net of tax — 69.1 70.2 139.3 Benefit (provision) for income taxes (0.2 ) (2.8 ) — (3.0 ) Net current period other comprehensive income (loss) $ 0.4 $ 58.1 $ 22.1 $ 80.6 Balance at March 31, 2020 $ 6.0 $ (399.3 ) $ (532.7 ) $ (926.0 ) The changes in Accumulated other comprehensive income (loss) for the three months ended March 31, 2019 was as follows: In millions Derivative Instruments Pension and OPEB Foreign Currency Translation Total Balance at December 31, 2018 $ 6.7 $ (454.0 ) $ (516.8 ) $ (964.1 ) Other comprehensive income (loss) before reclassifications (1.4 ) 0.3 (2.4 ) (3.5 ) Amounts reclassified from AOCI 0.1 12.9 — 13.0 Benefit (provision) for income taxes (0.5 ) (3.5 ) — (4.0 ) Net current period other comprehensive income (loss) $ (1.8 ) $ 9.7 $ (2.4 ) $ 5.5 Balance at March 31, 2019 $ 4.9 $ (444.3 ) $ (519.2 ) $ (958.6 )

Revenue (Notes)

Revenue (Notes)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. A majority of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. However, a portion of the Company's revenues are recognized over time as the customer simultaneously receives control as the Company performs work under a contract. For these arrangements, the cost-to-cost input method is used as it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Disaggregated Revenue Net revenues by geography and major type of good or service for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Americas Equipment $ 1,392.6 $ 1,483.2 Services and parts 705.2 661.1 Total Americas $ 2,097.8 $ 2,144.3 EMEA Equipment $ 248.8 $ 262.3 Services and parts 115.5 121.5 Total EMEA $ 364.3 $ 383.8 Asia Pacific Equipment $ 111.0 $ 192.8 Services and parts 68.2 82.8 Total Asia Pacific $ 179.2 $ 275.6 Total net revenues $ 2,641.3 $ 2,803.7 Revenue from goods and services transferred to customers at a point in time accounted for approximately 81% and 83% of the Company's revenue for the three months ended March 31, 2020 and 2019 , respectively. Contract Balances The opening and closing balances of contract assets and contract liabilities arising from contracts with customers for the period ended March 31, 2020 and December 31, 2019 were as follows: In millions March 31, December 31, 2019 Contract assets $ 204.5 $ 172.6 Contract liabilities 979.4 941.9 The timing of revenue recognition, billings and cash collections results in accounts receivable, contract assets, and customer advances and deposits (contract liabilities) on the Condensed Consolidated Balance Sheet. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Contract assets relate to the conditional right to consideration for any completed performance under the contract when costs are incurred in excess of billings under the percentage-of-completion methodology. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract liabilities relate to payments received in advance of performance under the contract or when the Company has a right to consideration that is unconditional before it transfers a good or service to the customer. Contract liabilities are recognized as revenue as (or when) the Company performs under the contract. During the three months ended March 31, 2020 , changes in contract asset and liability balances were not materially impacted by any other factors. Approximately 29% of the contract liability balance at December 31, 2019 was recognized as revenue during the three months ended March 31, 2020 . Additionally, approximately 37% of the contract liability balance at March 31, 2020 was classified as noncurrent and not expected to be recognized as revenue in the next 12 months.

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Share-Based Compensation	Share-Based Compensation The Company accounts for stock-based compensation plans in accordance with ASC 718, "Compensation - Stock Compensation" (ASC 718), which requires a fair-value based method for measuring the value of stock-based compensation. Fair value is measured once at the date of grant and is not adjusted for subsequent changes. The Company’s share-based compensation plans include programs for stock options, restricted stock units (RSUs), performance share units (PSUs) and deferred compensation. In connection with the completion of the Transaction, the provisions of the Company's existing share-based compensation plans required adjustment to the terms of outstanding awards in order to preserve the intrinsic value of the awards immediately before and after the separation. The outstanding awards will continue to vest over the original vesting period, which is generally three years from the grant date. The stock awards held as of February 29, 2020 were adjusted as follows: • Vested stock options - Outstanding stock options that were vested and exercisable at the time of the transaction were converted into vested and exercisable stock options of the Company. The number of underlying shares and exercise price for each award was adjusted to preserve the overall intrinsic value of the awards immediately prior to the separation. • Unvested stock options - Unvested stock options held at the time of the transaction were converted into stock options of the participants employer following the separation. The number of underlying shares and exercise price for each award was adjusted to preserve the overall intrinsic value of the awards immediately prior to the separation. • Restricted stock units - Outstanding RSUs held at the time of the transaction were converted into RSUs of the participants employer following the separation. The number of underlying shares was adjusted to preserve the overall intrinsic value of the awards immediately prior to the separation. • Performance share units - Active and outstanding PSU awards held at the time of the transaction were converted into active and outstanding PSUs of the Company. Post-transaction, the Company's employees will continue to participate in the plan at target levels with payout based on actual performance at the end of the respective three-year performance period for each award. Post-transaction, Ingersoll Rand Industrial employees will continue to participate in the plan with the target number of PSUs prorated based on the portion of the performance cycle completed as of the transaction date with payout based on actual performance at the end of the respective three year performance period for each award. The number of underlying shares was adjusted to preserve the overall intrinsic value of the awards immediately prior to the separation. Per ASC 718, an adjustment to the terms of a stock-based compensation award to preserve its value after an equity restructuring may result in significant incremental compensation cost if there was no requirement to make such an adjustment based on the awards existing terms. The Company reviewed the provisions of its existing share-based compensation plans and determined the Transaction required modification to the terms of outstanding awards. As a result, the Company incurred less than $0.1 million of incremental compensation costs during the three months ended March 31, 2020 . Compensation Expense Share-based compensation expense related to continuing operations is included in Selling and administrative expenses . The expense recognized for the three months ended March 31 was as follows: Three months ended In millions 2020 2019 Stock options $ 9.7 $ 11.8 RSUs 11.0 13.0 Performance shares 7.8 4.4 Deferred compensation 1.4 0.9 Other (1.8 ) 1.4 Pre-tax expense 28.1 31.5 Tax benefit (6.8 ) (7.6 ) After-tax expense $ 21.3 $ 23.9 Amounts recorded in continuing operations 20.3 21.2 Amounts recorded in discontinued operations 1.0 2.7 Total $ 21.3 $ 23.9 Grants issued during the three months ended March 31 were as follows: 2020 2019 Number granted Weighted- average fair value per award Number granted Weighted- average fair value per award Stock options 1,020,535 $ 16.75 1,259,344 $ 17.09 RSUs 189,546 $ 104.80 242,104 $ 100.70 Performance shares (1) 259,920 $ 141.88 306,352 $ 110.57 (1) The number of performance shares represents the maximum award level. For stock options, RSUs and PSUs granted prior to the completion of the Transaction, the number granted and weighted average fair value reflect historical information. Stock Options / RSUs Eligible participants may receive (i) stock options, (ii) RSUs or (iii) a combination of both stock options and RSUs. The fair value of each of the Company’s stock option and RSU awards is expensed on a straight-line basis over the required service period, which is generally the 3 -year vesting period. However, for stock options and RSUs granted to retirement eligible employees, the Company recognizes an expense for the entire fair value at the grant date. The average fair value of the stock options granted is determined using the Black-Scholes option-pricing model. The following assumptions were used during the three months ended March 31 : 2020 2019 Dividend yield 2.01 % 2.09 % Volatility 24.33 % 21.46 % Risk-free rate of return 0.56 % 2.49 % Expected life in years 4.8 4.8 A description of the significant assumptions used to estimate the fair value of the stock option awards is as follows: • Volatility - The expected volatility is based on a weighted average of the Company’s implied volatility and the most recent historical volatility of the Company’s stock commensurate with the expected life. • Risk-free rate of return - The Company applies a yield curve of continuous risk-free rates based upon the published U.S. Treasury spot rates on the grant date. • Expected life - The expected life of the Company’s stock option awards represents the weighted-average of the actual period since the grant date for all exercised or cancelled options and an expected period for all outstanding options. • Dividend yield - The Company determines the dividend yield based upon the expected quarterly dividend payments as of the grant date and the current fair market value of the Company’s stock. • Forfeiture Rate - The Company analyzes historical data of forfeited options to develop a reasonable expectation of the number of options to forfeit prior to vesting per year. This expected forfeiture rate is applied to the Company’s ongoing compensation expense; however, all expense is adjusted to reflect actual vestings and forfeitures. Performance Shares The Company has a Performance Share Program (PSP) for key employees. The program provides awards in the form of PSUs based on performance against pre-established objectives. The annual target award level is expressed as a number of the Company's ordinary shares based on the fair market value of the Company's stock on the date of grant. All PSUs are settled in the form of ordinary shares. Beginning with the 2018 grant year, PSU awards are earned based 50% upon a performance condition, measured by relative Cash Flow Return on Invested Capital (CROIC) to the industrial group of companies in the S&P 500 Index over a 3-year performance period, and 50% upon a market condition, measured by the Company's relative total shareholder return (TSR) as compared to the TSR of the industrial group of companies in the S&P 500 Index over a 3-year performance period. The fair value of the market condition is estimated using a Monte Carlo Simulation approach in a risk-neutral framework based upon historical volatility, risk-free rates and correlation matrix. Awards granted prior to 2018 were earned based 50% upon a performance condition, measured by relative EPS growth as compared to the industrial group of companies in the S&P 500 Index over a 3-year performance period, and 50% upon a market condition, measured by the Company's relative TSR as compared to the TSR of the industrial group of companies in the S&P 500 Index over a 3-year performance period. Deferred Compensation The Company allows key employees to defer a portion of their eligible compensation into a number of investment choices, including its ordinary share equivalents. Any amounts invested in ordinary share equivalents will be settled in ordinary shares of the Company at the time of distribution.

Restructuring Costs (Notes)

Restructuring Costs (Notes)	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	Restructuring Activities The Company incurs costs associated with announced restructuring initiatives intended to result in improved operating performance, profitability and working capital levels. Actions associated with these initiatives may include workforce reduction, improving manufacturing productivity, realignment of management structures and rationalizing certain assets. The following table details restructuring charges recorded during the three months ended March 31 : Three months ended In millions 2020 2019 Americas $ 20.8 $ 3.4 EMEA 0.6 0.5 Asia Pacific 1.1 1.3 Corporate and Other 3.1 0.9 Total $ 25.6 $ 6.1 Cost of goods sold $ 10.3 $ 3.4 Selling and administrative expenses 15.3 2.7 Total $ 25.6 $ 6.1 The changes in the restructuring reserve for the three months ended March 31, 2020 were as follows: In millions Americas EMEA Asia Pacific Corporate and Other Total December 31, 2019 $ 11.9 $ 2.8 $ 9.1 $ 1.6 $ 25.4 Additions, net of reversals (1) 16.8 0.6 1.1 3.1 21.6 Cash paid/other (11.9 ) (1.2 ) (9.1 ) (1.4 ) (23.6 ) March 31, 2020 $ 16.8 $ 2.2 $ 1.1 $ 3.3 $ 23.4 (1) Excludes the non-cash costs of asset rationalizations ( $4.0 million ). During the three months ended March 31, 2020 , costs associated with announced restructuring actions primarily included the following: • costs related to the reorganization of resources and facilities in response to the completion of the Transaction and separation of Ingersoll Rand Industrial; and • the plan to close two U.S. manufacturing facilities within the Americas and relocate production to another existing U.S. facility announced in 2018. Amounts recognized primarily relate to severance and exit costs. In addition, the Company also includes costs that are directly attributable to the restructuring activity but do not fall into the severance, exit or disposal categories. As of March 31, 2020 , the Company had $23.4 million accrued for costs associated with its ongoing restructuring actions, of which a majority is expected to be paid within one year.

Other, Net

Other, Net	3 Months Ended
	Mar. 31, 2020
Other Net [Abstract]
Other, Net	Other Income/(Expense), Net The components of Other income/(expense), net for the three months ended March 31 are as follows: Three months ended In millions 2020 2019 Interest income/(loss) $ (0.1 ) $ (1.1 ) Exchange gain/(loss) (4.2 ) (4.3 ) Other components of net periodic benefit cost (1.7 ) (9.8 ) Other activity, net 18.5 (2.8 ) Other income/(expense), net $ 12.5 $ (18.0 ) Other income /(expense), net includes the results from activities other than normal business operations such as interest income and foreign currency gains and losses on transactions that are denominated in a currency other than an entity’s functional currency. In addition, the Company includes the components of net periodic benefit cost for pension and post retirement obligations other than the service cost component. Other activity, net includes items associated with Trane U.S. Inc. for the settlement of asbestos-related claims, insurance settlements on asbestos-related matters and the revaluation of its liability for potential future claims and recoveries. In addition, the three months ended March 31, 2020 includes a $17.4 million adjustment to correct an overstatement of a legacy legal liability that originated in prior years. Refer to Note 21, "Commitments and Contingencies," for more information regarding asbestos-related matters.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company accounts for its Provision for income taxes in accordance with ASC 740, "Income Taxes" (ASC 740), which requires an estimate of the annual effective income tax rate for the full year to be applied to the respective interim period, taking into account year-to-date amounts and projected results for the full year. For the three months ended March 31, 2020 and March 31, 2019 , the Company's effective income tax rate was 49.1 % and 12.1 %, respectively. The effective income tax rate for the three months ended March 31, 2020 was higher than the U.S. statutory rate of 21% due to a $37.0 million non-cash charge related to the establishment of valuation allowances on net deferred tax assets, primarily net operating losses in certain tax jurisdictions, as a result of the completion of the Transaction, U.S. state and local taxes and certain non-deductible employee expenses. These amounts were partially offset by excess tax benefits from employee share-based payments, the deduction for Foreign Derived Intangible Income (FDII) and earnings in non-U.S. jurisdictions, which in aggregate have a lower effective tax rate. The establishment of the valuation allowances increased the effective tax rate by 35.7%. The effective tax rate for the three months ended March 31, 2019 was lower than the U.S. statutory rate of 21% due to excess tax benefits from employee share-based payments, the deduction for FDII and earnings in non-U.S. jurisdictions, which in aggregate have a lower effective tax rate. These amounts were partially offset by U.S. state and local taxes and certain non-deductible employee expenses. Total unrecognized tax benefits as of March 31, 2020 and December 31, 2019 were $ 63.7 million and $ 63.5 million , respectively. Although management believes its tax positions and related provisions reflected in the Condensed Consolidated Financial Statements are fully supportable, it recognizes that these tax positions and related provisions may be challenged by various tax authorities. These tax positions and related provisions are reviewed on an ongoing basis and are adjusted as additional facts and information become available, including progress on tax audits, changes in interpretations of tax laws, developments in case law and closing of statute of limitations. To the extent that the ultimate results differ from the original or adjusted estimates of the Company, the effect will be recorded in Provision for income taxes . The Provision for income taxes involves a significant amount of management judgment regarding interpretation of relevant facts and laws in the jurisdictions in which the Company operates. Future changes in applicable laws, projected levels of taxable income and tax planning could change the effective tax rate and tax balances recorded by the Company. In addition, tax authorities periodically review income tax returns filed by the Company and can raise issues regarding its filing positions, timing and amount of income or deductions, and the allocation of income among the jurisdictions in which the Company operates. A significant period of time may elapse between the filing of an income tax return and the ultimate resolution of an issue raised by a revenue authority with respect to that return. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as Brazil, Canada, China, France, Germany, Ireland, Italy, Mexico, Spain, the Netherlands, the United Kingdom and the United States. These examinations on their own, or any subsequent litigation related to the examinations, may result in additional taxes or penalties against the Company. If the ultimate result of these audits differ from original or adjusted estimates, they could have a material impact on the Company’s tax provision. In general, the examination of the Company’s material tax returns is complete or effectively settled for the years prior to 2011, with certain matters prior to 2011 being resolved through appeals and litigation and also unilateral procedures as provided for under double tax treaties.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2020
Discontinued Operations [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Discontinued Operations The components of Discontinued operations, net of tax for the three months ended March 31 were as follows: In millions 2020 2019 Net revenues $ 469.8 $ 772.2 Cost of goods sold (315.8 ) (528.1 ) Selling and administrative expenses (1) (221.4 ) (162.1 ) Operating income (67.4 ) 82.0 Pre-tax earnings (loss) from discontinued operations (75.5 ) 79.4 Tax benefit (expense) (3.2 ) (23.0 ) Discontinued operations, net of tax $ (78.7 ) $ 56.4 (1) Includes pre-tax separation costs of $99.1 million ( $83.4 million net of tax), primarily related to legal, consulting and advisory fees, during the three months ended March 31, 2020. Separation of Industrial Segment Businesses On February 29, 2020, the Company completed the Transaction with Gardner Denver whereby the Company separated Ingersoll Rand Industrial which then merged with a wholly-owned subsidiary of Gardner Denver. In accordance with GAAP, the historical results of Ingersoll Rand Industrial are presented as a discontinued operation in the Condensed Consolidated Statement of Comprehensive Income and Condensed Consolidated Statement of Cash Flows. In addition, the assets and liabilities of Ingersoll Rand Industrial have been recast to held-for-sale at December 31, 2019. Net revenues and earnings from operations, net of tax of Ingersoll Rand Industrial for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Net revenues $ 469.8 $ 772.2 Earnings (loss) attributable to Trane Technologies plc (1) (71.6 ) 57.8 Earnings (loss) attributable to noncontrolling interests 0.5 0.7 Earnings (loss) from operations, net of tax (1) $ (71.1 ) $ 58.5 (1) Includes pre-tax separation costs of $99.1 million ( $83.4 million net of tax), primarily related to legal, consulting and advisory fees, during the three months ended March 31, 2020. The components of Ingersoll Rand Industrial's assets and liabilities recorded as held-for-sale on the Condensed Consolidated Balance Sheet at December 31, 2019 were as follows: In millions December 31, 2019 Assets Current assets (1) $ 1,130.6 Property, plant and equipment, net 454.3 Goodwill 1,657.4 Intangible assets, net 825.2 Other noncurrent assets 139.7 Assets held-for-sale $ 4,207.2 Liabilities Current liabilities $ 823.7 Noncurrent liabilities 376.7 Liabilities held-for-sale $ 1,200.4 (1) Includes $25 million cash and cash equivalents in accordance with the merger agreement. Other Discontinued Operations Other discontinued operations, net of tax related to retained obligations from previously sold businesses that primarily include ongoing expenses for postretirement benefits, product liability and legal costs. In addition, the Company includes costs associated with Trane Technologies Company LLC for the settlement and defense of asbestos-related claims, insurance settlements on asbestos-related matters and the revaluation of its liability for potential future claims and recoveries. The components of Discontinued operations, net of tax for the three months ended March 31 were as follows: In millions 2020 2019 Ingersoll Rand Industrial, net of tax $ (71.1 ) $ 58.5 Other discontinued operations, net of tax (7.6 ) (2.1 ) Discontinued operations, net of tax $ (78.7 ) $ 56.4

Earnings Per Share (EPS)

Earnings Per Share (EPS)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share (EPS)	Earnings Per Share (EPS) Basic EPS is calculated by dividing Net earnings attributable to Trane Technologies plc by the weighted-average number of ordinary shares outstanding for the applicable period. Diluted EPS is calculated after adjusting the denominator of the basic EPS calculation for the effect of all potentially dilutive ordinary shares, which in the Company’s case, includes shares issuable under share-based compensation plans. The following table summarizes the weighted-average number of ordinary shares outstanding for basic and diluted earnings per share calculations for the three months ended March 31 : Three months ended In millions, except per share amounts 2020 2019 Weighted-average number of basic shares 239.5 242.5 Shares issuable under incentive stock plans 2.8 2.7 Weighted-average number of diluted shares 242.3 245.2 Anti-dilutive shares 0.5 1.4 Dividends declared per ordinary share $ 0.53 $ 0.53

Business Segment Information

Business Segment Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Business Segment Information	Business Segment Information The Company operates under three regional operating segments designed to create deep customer focus and relevance in markets around the world. Intercompany sales between segments are immaterial. • The Company's Americas segment innovates for customers in the North America and Latin America regions. The Americas segment encompasses commercial heating and cooling systems, building controls, and energy services and solutions; residential heating and cooling; and transport refrigeration systems and solutions. • The Company's EMEA segment innovates for customers in the Europe, Middle East and Africa region. The EMEA segment encompasses heating and cooling systems, services and solutions for commercial buildings, and transport refrigeration systems and solutions. • The Company's Asia Pacific segment innovates for customers throughout the Asia Pacific region and India. The Asia Pacific segment encompasses heating and cooling systems, services and solutions for commercial buildings and transport refrigeration systems and solutions. Beginning in 2020, the Company’s CODM measures profit or loss using segment adjusted EBITDA, or GAAP net earnings excluding interest expense, income taxes, depreciation and amortization, restructuring, unallocated corporate expenses and discontinued operations. The Company believes that segment adjusted EBITDA provides profitability as well as earnings power and the ability to generate cash. As a result, the Company's CODM evaluates the financial performance of the business segments based on segment adjusted EBITDA. Segment adjusted EBITDA is a key component for consideration in performance reviews, compensation and resource allocation. For these reasons, the Company believes that segment adjusted EBITDA represents the most relevant measure of segment profit and loss. Segment adjusted EBITDA may not be comparable to similarly-titled measures used by other companies and should not be considered a substitute for net earnings or other results reported in accordance with GAAP. A summary of operations by reportable segment for the three months ended March 31 was as follows: Three months ended In millions 2020 2019 Net revenues Americas $ 2,097.8 $ 2,144.3 EMEA 364.3 383.8 Asia Pacific 179.2 275.6 Total net revenues $ 2,641.3 $ 2,803.7 Segment adjusted EBITDA Americas $ 262.1 $ 297.8 EMEA 43.2 44.7 Asia Pacific 10.6 27.5 Total segment adjusted EBITDA $ 315.9 $ 370.0 Reconciliation of segment adjusted EBITDA to earnings before income taxes Total segment adjusted EBITDA $ 315.9 $ 370.0 Interest expense (63.1 ) (51.0 ) Depreciation and amortization (75.0 ) (70.9 ) Restructuring costs (25.6 ) (6.1 ) Unallocated corporate expenses (48.4 ) (74.5 ) Earnings before income taxes $ 103.8 $ 167.5

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Abstract
Commitments and Contingencies	Commitments and Contingencies The Company is involved in various litigations, claims and administrative proceedings, including those related to asbestos, environmental, and product liability matters. In accordance with ASC 450, "Contingencies" (ASC 450), the Company records accruals for loss contingencies when it is both probable that a liability will be incurred and the amount of the loss can be reasonably estimated. Amounts recorded for identified contingent liabilities are estimates, which are reviewed periodically and adjusted to reflect additional information when it becomes available. Subject to the uncertainties inherent in estimating future costs for contingent liabilities, except as expressly set forth in this note, management believes that any liability which may result from these legal matters would not have a material adverse effect on the financial condition, results of operations, liquidity or cash flows of the Company. Asbestos-Related Matters Certain wholly-owned subsidiaries and former companies of ours are named as defendants in asbestos-related lawsuits in state and federal courts. In virtually all of the suits, a large number of other companies have also been named as defendants. The vast majority of those claims have been filed against either Trane Technologies Company LLC, formerly known as Ingersoll-Rand Company, or Trane U.S. Inc. (Trane) and generally allege injury caused by exposure to asbestos contained in certain historical products sold by Trane Technologies Company LLC or Trane, primarily pumps, boilers and railroad brake shoes. None of our existing or previously-owned businesses were a producer or manufacturer of asbestos. The Company engages an outside expert to perform a detailed analysis and project an estimated range of the Company’s total liability for pending and unasserted future asbestos-related claims. In accordance with ASC 450, the Company records the liability at the low end of the range as it believes that no amount within the range is a better estimate than any other amount. Asbestos-related defense costs are excluded from the liability and are recorded separately as services are incurred. The methodology used to prepare estimates relies upon and includes the following factors, among others: • the outside expert’s interpretation of a widely accepted forecast of the population likely to have been occupationally exposed to asbestos; • epidemiological studies estimating the number of people likely to develop asbestos-related diseases such as mesothelioma and lung cancer; • the Company’s historical experience with the filing of non-malignancy claims and claims alleging other types of malignant diseases filed against the Company relative to the number of lung cancer claims filed against the Company; • the outside expert’s analysis of the number of people likely to file an asbestos-related personal injury claim against the Company based on such epidemiological and historical data and the Company’s claims history; • an analysis of the Company’s pending cases, by type of disease claimed and by year filed; • an analysis of the Company’s history to determine the average settlement and resolution value of claims, by type of disease claimed; • an adjustment for inflation in the future average settlement value of claims, at a 2.5% annual inflation rate, adjusted downward to 1.0% to take account of the declining value of claims resulting from the aging of the claimant population; and • an analysis of the period over which the Company has and is likely to resolve asbestos-related claims against it in the future (currently projected through 2053). At March 31, 2020 and December 31, 2019 , over 73 percent of the open and active claims against the Company are non-malignant or unspecified disease claims. In addition, the Company has a number of claims which have been placed on inactive or deferred dockets and expected to have little or no settlement value against the Company. The Company’s liability for asbestos-related matters and the asset for probable asbestos-related insurance recoveries were included in the following balance sheet accounts: In millions March 31, December 31, Accrued expenses and other current liabilities $ 64.0 $ 63.0 Other noncurrent liabilities 468.6 484.4 Total asbestos-related liabilities $ 532.6 $ 547.4 Other current assets $ 48.7 $ 66.2 Other noncurrent assets 229.0 237.8 Total asset for probable asbestos-related insurance recoveries $ 277.7 $ 304.0 The Company's asbestos insurance receivable related to Trane Technologies Company LLC and Trane were $ 166.6 million and $ 111.1 million , respectively, at March 31, 2020 , and $ 188.7 million and $ 115.3 million , respectively, at December 31, 2019 . These receivables attributable to Trane Technologies Company LLC and Trane for probable insurance recoveries as of March 31, 2020 are entirely supported by settlement agreements between Trane Technologies Company LLC and Trane and their respective insurance carriers. Most of these settlement agreements constitute “coverage-in-place” arrangements, in which the insurer signatories agree to reimburse Trane Technologies Company LLC or Trane, as applicable, for specified portions of their respective costs for asbestos bodily injury claims and Trane Technologies Company LLC or Trane, as applicable, agrees to certain claims-handling protocols and grants to the insurer signatories certain releases and indemnifications. The costs associated with the settlement and defense of asbestos-related claims, insurance settlements on asbestos-related matters and the revaluation of the Company's liability for potential future claims and recoveries are included in the income statement within continuing operations or discontinued operations depending on the business to which they relate. Income and expenses associated with Trane Technologies Company LLC's asbestos-related matters are recorded within discontinued operations as they relate to previously divested businesses, primarily Ingersoll-Dresser Pump, which was sold by the Company in 2000. Income and expenses associated with Trane’s asbestos-related matters are recorded within continuing operations. The three months ended March 31, 2020 includes a $17.4 million adjustment to correct an overstatement of a legacy legal liability that originated in prior years. The net income (expense) associated with these transactions, for the three months ended March 31 , were as follows: Three months ended In millions 2020 2019 Continuing operations $ 15.6 $ (1.8 ) Discontinued operations (4.9 ) (3.0 ) Total $ 10.7 $ (4.8 ) The amounts recorded by the Company for asbestos-related liabilities and insurance-related assets are based on currently available information. The Company’s actual liabilities or insurance recoveries could be significantly higher or lower than those recorded if assumptions used in the calculations vary significantly from actual results. Key assumptions underlying the estimated asbestos-related liabilities include the number of people occupationally exposed and likely to develop asbestos-related diseases such as mesothelioma and lung cancer, the number of people likely to file an asbestos-related personal injury claim against the Company, the average settlement and resolution of each claim and the percentage of claims resolved with no payment. Furthermore, predictions with respect to estimates of the liability are subject to greater uncertainty as the projection period lengthens. Other factors that may affect the Company’s liability include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, reforms that may be made by state and federal courts, and the passage of state or federal tort reform legislation. The aggregate amount of the stated limits in insurance policies available to the Company for asbestos-related claims acquired, over many years and from many different carriers, is substantial. However, limitations in that coverage, primarily due to the considerations described above, are expected to result in the projected total liability to claimants substantially exceeding the probable insurance recovery. Environmental Matters The Company continues to be dedicated to environmental and sustainability programs to minimize the use of natural resources, and reduce the utilization and generation of hazardous materials from our manufacturing processes and to remediate identified environmental concerns. As to the latter, the Company is currently engaged in site investigations and remediation activities to address environmental cleanup from past operations at current and former manufacturing facilities. The Company is sometimes a party to environmental lawsuits and claims and has received notices of potential violations of environmental laws and regulations from the Environmental Protection Agency and similar state authorities. It has also been identified as a potentially responsible party (PRP) for cleanup costs associated with off-site waste disposal at federal Superfund and state remediation sites. For all such sites, there are other PRPs and, in most instances, the Company’s involvement is minimal. In estimating its liability, the Company has assumed it will not bear the entire cost of remediation of any site to the exclusion of other PRPs who may be jointly and severally liable. The ability of other PRPs to participate has been taken into account, based on the Company's understanding of the parties’ financial condition and probable contributions on a per site basis. Additional lawsuits and claims involving environmental matters are likely to arise from time to time in the future. Reserves for environmental matters are classified as Accrued expenses and other current liabilities or Other noncurrent liabilities based on their expected term. As of March 31, 2020 and December 31, 2019 , the Company has recorded reserves for environmental matters of $ 40.4 million and $ 40.2 million , respectively. Of these amounts, $ 37.8 million and $37.5 million , respectively, relate to remediation of sites previously disposed of by the Company. Warranty Liability Standard product warranty accruals are recorded at the time of sale and are estimated based upon product warranty terms and historical experience. The Company assesses the adequacy of its liabilities and will make adjustments as necessary based on known or anticipated warranty claims, or as new information becomes available. The changes in the standard product warranty liability for the three months ended March 31 were as follows: In millions 2020 2019 Balance at beginning of period $ 251.4 $ 245.6 Reductions for payments (32.7 ) (31.2 ) Accruals for warranties issued during the current period 30.1 33.5 Changes to accruals related to preexisting warranties (5.7 ) (1.0 ) Translation (0.9 ) (0.3 ) Balance at end of period $ 242.2 $ 246.6 Standard product warranty liabilities are classified as Accrued expenses and other current liabilities or Other noncurrent liabilities based on their expected term. The Company's total current standard product warranty reserve at March 31, 2020 and December 31, 2019 was $ 118.8 million and $ 124.9 million , respectively. The Company's extended warranty liability represents the deferred revenue associated with its extended warranty contracts and is amortized into Net revenues on a straight-line basis over the life of the contract, unless another method is more representative of the costs incurred. The Company assesses the adequacy of its liability by evaluating the expected costs under its existing contracts to ensure these expected costs do not exceed the extended warranty liability. The changes in the extended warranty liability for the three months ended March 31 were as follows: In millions 2020 2019 Balance at beginning of period $ 302.8 $ 290.6 Amortization of deferred revenue for the period (28.8 ) (27.1 ) Additions for extended warranties issued during the period 30.9 28.4 Changes to accruals related to preexisting warranties (0.2 ) (0.2 ) Translation (0.9 ) — Balance at end of period $ 303.8 $ 291.7 The extended warranty liability is classified as Accrued expenses and other current liabilities or Other noncurrent liabilities based on the timing of when the deferred revenue is expected to be amortized into revenue. The Company's total current extended warranty liability at March 31, 2020 and December 31, 2019 was $ 107.1 million and $ 107.3 million , respectively.

COVID-19 Global Pandemic (Notes

COVID-19 Global Pandemic (Notes)	3 Months Ended
	Mar. 31, 2020
COVID-19 Global Pandemic [Abstract]
COVID-19 Global Pandemic [Text Block]	Note 22. COVID-19 Global Pandemic On March 11, 2020, the World Health Organization declared the outbreak of a respiratory disease caused by a newly discovered coronavirus, known now as COVID-19, as a global pandemic and recommended containment and mitigation measures worldwide. In response, many countries have implemented measures to combat the outbreak which impacted global business operations and resulted in a Company decision to temporarily close or limit its workforce to essential crews within many facilities throughout the world in order to ensure employee safety. In compliance with government protocols with respect to stay-in-place procedures, the Company's non-essential employees were instructed to work from home. Within the United States, the Company has been designated as an essential service provider by the U.S. Department of Homeland Security and will continue operating its plants, installing and servicing its products. During the three months ended March 31, 2020, the Company was adversely impacted by the COVID-19 global pandemic. Temporary facility closures during January and February disrupted results in the Asia Pacific region. Commencing in March and through the date of this filing, impacts were more widely felt throughout operations in the Americas and EMEA. As a result, COVID-19 impacted the Company's business globally, including, but not limited to, lower revenue volumes, temporary facility closures, supply chain disruptions and unfavorable foreign currency exchange rate movements. The Company will continue to monitor its liquidity needs and ability to access capital markets. Operationally, the Company’s financial reporting systems, internal control over financial reporting and disclosure controls and procedures continue to operate effectively despite a remote workforce. The Company will continue to monitor the ongoing situation. Through the date of issuance of this report, management did not identify any impairment charges in long-lived tangible or intangible assets (including goodwill) as a result of the global pandemic. However, due to significant uncertainty surrounding the COVID-19 global pandemic, management's judgment regarding this could change in the future. In addition, while the Company's results of operations, cash flows and financial condition could be negatively impacted, the extent of the impact cannot be estimated with certainty at this time. As part of the response to COVID-19 global pandemic, many countries are implementing emergency economic relief plans as a way of minimizing the economic impact of this health crisis. The Company is evaluating the potential benefits from certain of these measures and will continue to monitor the plans as they are finalized and implemented. In the United States, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted on March 27, 2020 providing numerous tax provisions and other stimulus measures. The Company is currently anticipating an impact of the CARES Act, which includes the deferral of employer social security payroll tax payments under the CARES Act until January 1, 2021, with 50 percent owed on December 31, 2021 and the other half owed on December 31, 2022.

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory, Net [Abstract]
MajorClassesOfInventory [Table Text Block]	The major classes of inventory were as follows: In millions March 31, December 31, Raw materials $ 348.8 $ 333.5 Work-in-process 173.8 173.7 Finished goods 973.4 804.9 1,496.0 1,312.1 LIFO reserve (32.3 ) (33.5 ) Total $ 1,463.7 $ 1,278.6

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill Abstract
Changes in Goodwill Carrying Amounts	The reassigned amounts of goodwill as of December 31, 2019 and the changes in the carrying amount of goodwill for the three months ended March 31, 2020 were as follows: In millions Americas EMEA Asia Pacific Total Net balance as of December 31, 2019 $ 3,858.8 $ 731.1 $ 535.8 $ 5,125.7 Currency translation (12.1 ) (24.3 ) (7.0 ) (43.4 ) Net balance as of March 31, 2020 $ 3,846.7 $ 706.8 $ 528.8 $ 5,082.3 The net goodwill balances at March 31, 2020 and December 31, 2019 include $ 2,496.0 million of accumulated impairment. The accumulated impairment relates entirely to a charge recorded in 2008.

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Intangible Assets Abstract
Schedule of Intangible Asset Net of Goodwill	The gross amount of the Company’s intangible assets and related accumulated amortization were as follows: March 31, 2020 December 31, 2019 In millions Gross carrying amount Accumulated amortization Net carrying amount Gross carrying amount Accumulated amortization Net carrying amount Customer relationships $ 1,919.6 $ (1,262.9 ) $ 656.7 $ 1,928.5 $ (1,239.2 ) $ 689.3 Patents 164.4 (162.8 ) 1.6 171.8 (169.7 ) 2.1 Other 40.3 (34.3 ) 6.0 40.4 (33.7 ) 6.7 Total finite-lived intangible assets 2,124.3 (1,460.0 ) 664.3 2,140.7 (1,442.6 ) 698.1 Trademarks (indefinite-lived) 2,624.7 — 2,624.7 2,625.5 — 2,625.5 Total $ 4,749.0 $ (1,460.0 ) $ 3,289.0 $ 4,766.2 $ (1,442.6 ) $ 3,323.6

Debt and Credit Facilities (Tab

Debt and Credit Facilities (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Credit Facilities
Short-Term Borrowings and Current Maturities of Long-Term Debt	Short-term borrowings and current maturities of long-term debt consisted of the following: In millions March 31, December 31, Debentures with put feature $ 343.0 $ 343.0 2.625% Senior notes due 2020 (1) 299.9 299.8 2.900% Senior notes due 2021 (2) 299.3 — Other current maturities of long-term debt 7.5 7.5 Total $ 949.7 $ 650.3 (1) The 2.625% Senior notes due in May 2020 were redeemed in April 2020. (2) The 2.900% Senior notes are due in February 2021.
Long-Term Debt Excluding Current Maturities	Long-term debt , excluding current maturities, consisted of the following: In millions March 31, December 31, 2.900% Senior notes due 2021 (1) — 299.1 9.000% Debentures due 2021 124.9 124.9 4.250% Senior notes due 2023 697.9 697.8 7.200% Debentures due 2020-2025 37.3 37.3 3.550% Senior notes due 2024 496.8 496.6 6.480% Debentures due 2025 149.7 149.7 3.500% Senior notes due 2026 396.9 396.8 3.750% Senior notes due 2028 545.2 545.1 3.800% Senior notes due 2029 743.7 743.6 5.750% Senior notes due 2043 494.6 494.5 4.650% Senior notes due 2044 296.0 295.9 4.300% Senior notes due 2048 296.0 296.0 4.500% Senior notes due 2049 345.5 345.5 Other loans and notes 0.3 0.1 Total $ 4,624.8 $ 4,922.9 (1) The 2.900% Senior notes are due in February 2021.

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivatives, Fair Value [Line Items]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The fair values of derivative instruments included within the Condensed Consolidated Balance Sheets were as follows: Derivative assets Derivative liabilities In millions March 31, December 31, March 31, December 31, Derivatives designated as hedges: Currency derivatives $ 0.6 $ 0.1 $ 4.2 $ 3.9 Derivatives not designated as hedges: Currency derivatives 5.8 1.0 1.8 3.3 Total derivatives $ 6.4 $ 1.1 $ 6.0 $ 7.2 Asset and liability derivatives included in the table above are recorded within Other current assets and Accrued expenses and other current liabilities , respectively.
Schedule Of Derivatives Designated As Hedges Affecting Condensed Consolidated Income Statement And Accumulated Other Comprehensive Income [Text Block]	The following table represents the amounts associated with derivatives designated as hedges affecting Net earnings and AOCI for the three months ended March 31 : Amount of gain (loss) Location of gain (loss) reclassified from Amount of gain (loss) In millions 2020 2019 2020 2019 Currency derivatives designated as hedges $ 0.3 $ (1.4 ) Cost of goods sold $ (0.5 ) $ (0.3 ) Interest rate swaps & locks — — Interest expense 0.2 0.2 Total $ 0.3 $ (1.4 ) $ (0.3 ) $ (0.1 )
Schedule of Gains and Losses of Derivative Financial Instruments Not Designated as Hedges	The following table represents the amounts associated with derivatives not designated as hedges affecting Other income/(expense), net for the three months ended March 31 : Amount of gain (loss) In millions 2020 2019 Currency derivatives not designated as hedges $ 8.3 $ (3.0 ) Total $ 8.3 $ (3.0 )

Financial Instruments Effects o

Financial Instruments Effects on Comprehensive Income (Tables)	3 Months Ended
	Mar. 31, 2020
Effects on the Consolidated Statement of Comprehensive Income [Abstract]
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]	The following table presents the effects of the Company's designated financial instruments on the associated financial statement line item within the Consolidated Statement of Comprehensive Income where the financial instruments are recorded for the three months ended March 31 : Classification and amount of gain (loss) recognized in income on cash flow hedging relationships 2020 2019 In millions Cost of goods sold Interest expense Cost of goods sold Interest expense Total amounts presented in the Consolidated Statements of Comprehensive Income $ (1,898.8 ) $ (63.1 ) $ (1,989.2 ) $ (51.0 ) Gain (loss) on cash flow hedging relationships Currency derivatives: Amount of gain (loss) reclassified from AOCI and recognized into Net earnings $ (0.5 ) $ — $ (0.3 ) $ — Amount excluded from effectiveness testing recognized in net earnings based on changes in fair value and amortization $ (0.6 ) $ — $ (0.6 ) $ — Interest rate swaps & locks: Amount of gain (loss) reclassified from AOCI and recognized into Net earnings $ — $ 0.2 $ — $ 0.2

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, by Balance Sheet Grouping [Table Text Block]	The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 : In millions Fair Value Fair value measurements Level 1 Level 2 Level 3 Assets: Derivative instruments $ 6.4 $ — $ 6.4 $ — Liabilities: Derivative instruments $ 6.0 $ — $ 6.0 $ — The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 : In millions Fair Value Fair value measurements Level 1 Level 2 Level 3 Assets: Derivative instruments $ 1.1 $ — $ 1.1 $ — Liabilities: Derivative instruments $ 7.2 $ — $ 7.2 $ —

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Summary of Company's Lease Portfolio and Balance Sheet Components	The following table includes a summary of the Company's lease portfolio and Balance Sheet classification: In millions (except lease term and discount rate) Classification March 31, December 31, Assets Operating lease right-of-use assets (1) Other noncurrent assets $ 453.7 $ 469.4 Liabilities Operating lease current Other current liabilities 143.4 145.0 Operating lease noncurrent Other noncurrent liabilities 315.9 329.9 Weighted average remaining lease term 4.3 years 4.3 years Weighted average discount rate 3.5 % 3.6 % (1) Per ASC 842, prepaid lease payments and lease incentives are recorded as part of the right-of-use asset. The net impact was $5.6 million and $5.5 million at March 31, 2020 and December 31, 2019 , respectively.
Schedule of Lease Cost and Related Cash Flow Information	The following table includes lease costs and related cash flow information for the three months ended March 31 : Three months ended In millions 2020 2019 Operating lease expense $ 42.9 $ 38.7 Variable lease expense 6.2 6.4 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases 42.7 38.3 Right-of-use assets obtained in exchange for new operating lease liabilities 43.5 38.5
Maturities of Lease Obligations	Maturities of lease obligations were as follows: In millions March 31, Operating leases: Remaining nine months of 2020 $ 121.1 2021 130.2 2022 93.2 2023 64.3 2024 37.5 After 2024 51.6 Total lease payments $ 497.9 Less: Interest (38.6 ) Present value of lease liabilities $ 459.3

Pensions and Postretirement B_2

Pensions and Postretirement Benefits Other than Pensions (Tables)	3 Months Ended
	Mar. 31, 2020
Pension Plan, Defined Benefit [Member]
Schedule of Net Periodic Benefit Cost	The components of the Company’s net periodic pension benefit cost for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Service cost $ 17.7 $ 18.1 Interest cost 22.5 29.8 Expected return on plan assets (31.9 ) (34.6 ) Net amortization of: Prior service costs 1.3 1.2 Net actuarial (gains) losses 11.3 13.4 Net periodic pension benefit cost $ 20.9 $ 27.9 Net curtailment and settlement (gains) losses (3.6 ) 1.6 Net periodic pension benefit cost after net curtailment and settlement (gains) losses $ 17.3 $ 29.5 Amounts recorded in continuing operations: Operating income $ 14.8 $ 14.3 Other income/(expense), net 0.7 8.3 Amounts recorded in discontinued operations 1.8 6.9 Total $ 17.3 $ 29.5
Other Postretirement Benefit Plan, Defined Benefit [Member]
Schedule of Net Periodic Benefit Cost	The components of net periodic postretirement benefit cost for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Service cost $ 0.6 $ 0.6 Interest cost 2.6 3.9 Net amortization of: Prior service gains — (0.1 ) Net actuarial (gains) losses (1.1 ) (1.6 ) Net periodic postretirement benefit cost $ 2.1 $ 2.8 Amounts recorded in continuing operations: Operating income $ 0.6 $ 0.6 Other income/(expense), net 1.0 1.5 Amounts recorded in discontinued operations 0.5 0.7 Total $ 2.1 $ 2.8

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Reconciliation of Ordinary Shares	Changes in ordinary shares and treasury shares for the three months ended March 31, 2020 were as follows: In millions Ordinary shares issued Ordinary shares held in treasury December 31, 2019 262.8 24.5 Shares issued under incentive plans, net 0.9 — March 31, 2020 263.7 24.5
Schedule of Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The changes in Accumulated other comprehensive income (loss) for the three months ended March 31, 2020 was as follows: In millions Derivative Instruments Pension and OPEB Foreign Currency Translation Total Balance at December 31, 2019 $ 5.6 $ (457.4 ) $ (554.8 ) $ (1,006.6 ) Other comprehensive income (loss) before reclassifications 0.3 (19.7 ) (48.1 ) (67.5 ) Amounts reclassified from AOCI 0.3 11.5 — 11.8 Separation of Ingersoll Rand Industrial, net of tax — 69.1 70.2 139.3 Benefit (provision) for income taxes (0.2 ) (2.8 ) — (3.0 ) Net current period other comprehensive income (loss) $ 0.4 $ 58.1 $ 22.1 $ 80.6 Balance at March 31, 2020 $ 6.0 $ (399.3 ) $ (532.7 ) $ (926.0 ) The changes in Accumulated other comprehensive income (loss) for the three months ended March 31, 2019 was as follows: In millions Derivative Instruments Pension and OPEB Foreign Currency Translation Total Balance at December 31, 2018 $ 6.7 $ (454.0 ) $ (516.8 ) $ (964.1 ) Other comprehensive income (loss) before reclassifications (1.4 ) 0.3 (2.4 ) (3.5 ) Amounts reclassified from AOCI 0.1 12.9 — 13.0 Benefit (provision) for income taxes (0.5 ) (3.5 ) — (4.0 ) Net current period other comprehensive income (loss) $ (1.8 ) $ 9.7 $ (2.4 ) $ 5.5 Balance at March 31, 2019 $ 4.9 $ (444.3 ) $ (519.2 ) $ (958.6 )

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of revenues	Net revenues by geography and major type of good or service for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Americas Equipment $ 1,392.6 $ 1,483.2 Services and parts 705.2 661.1 Total Americas $ 2,097.8 $ 2,144.3 EMEA Equipment $ 248.8 $ 262.3 Services and parts 115.5 121.5 Total EMEA $ 364.3 $ 383.8 Asia Pacific Equipment $ 111.0 $ 192.8 Services and parts 68.2 82.8 Total Asia Pacific $ 179.2 $ 275.6 Total net revenues $ 2,641.3 $ 2,803.7
Schedule of assets and liabilities from contracts with customers	The opening and closing balances of contract assets and contract liabilities arising from contracts with customers for the period ended March 31, 2020 and December 31, 2019 were as follows: In millions March 31, December 31, 2019 Contract assets $ 204.5 $ 172.6 Contract liabilities 979.4 941.9 The timing of revenue recognition, billings and cash collections results in accounts receivable, contract assets, and customer advances and deposits (contract liabilities) on the Condensed Consolidated Balance Sheet. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Contract assets relate to the conditional right to consideration for any completed performance under the contract when costs are incurred in excess of billings under the percentage-of-completion methodology. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract liabilities relate to payments received in advance of performance under the contract or when the Company has a right to consideration that is unconditional before it transfers a good or service to the customer. Contract liabilities are recognized as revenue as (or when) the Company performs under the contract. During the three months ended March 31, 2020 , changes in contract asset and liability balances were not materially impacted by any other factors. Approximately 29% of the contract liability balance at December 31, 2019 was recognized as revenue during the three months ended March 31, 2020 . Additionally, approximately 37% of the contract liability balance at March 31, 2020 was classified as noncurrent and not expected to be recognized as revenue in the next 12 months.

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Share-Based Compensation Expense	The expense recognized for the three months ended March 31 was as follows: Three months ended In millions 2020 2019 Stock options $ 9.7 $ 11.8 RSUs 11.0 13.0 Performance shares 7.8 4.4 Deferred compensation 1.4 0.9 Other (1.8 ) 1.4 Pre-tax expense 28.1 31.5 Tax benefit (6.8 ) (7.6 ) After-tax expense $ 21.3 $ 23.9 Amounts recorded in continuing operations 20.3 21.2 Amounts recorded in discontinued operations 1.0 2.7 Total $ 21.3 $ 23.9
Grants of Stock Options and RSUs	Grants issued during the three months ended March 31 were as follows: 2020 2019 Number granted Weighted- average fair value per award Number granted Weighted- average fair value per award Stock options 1,020,535 $ 16.75 1,259,344 $ 17.09 RSUs 189,546 $ 104.80 242,104 $ 100.70 Performance shares (1) 259,920 $ 141.88 306,352 $ 110.57 (1) The number of performance shares represents the maximum award level.
Average fair value of stock options, assumptions	The following assumptions were used during the three months ended March 31 : 2020 2019 Dividend yield 2.01 % 2.09 % Volatility 24.33 % 21.46 % Risk-free rate of return 0.56 % 2.49 % Expected life in years 4.8 4.8

Restructuring Costs (Tables)

Restructuring Costs (Tables)	3 Months Ended
	Mar. 31, 2020
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	The changes in the restructuring reserve for the three months ended March 31, 2020 were as follows: In millions Americas EMEA Asia Pacific Corporate and Other Total December 31, 2019 $ 11.9 $ 2.8 $ 9.1 $ 1.6 $ 25.4 Additions, net of reversals (1) 16.8 0.6 1.1 3.1 21.6 Cash paid/other (11.9 ) (1.2 ) (9.1 ) (1.4 ) (23.6 ) March 31, 2020 $ 16.8 $ 2.2 $ 1.1 $ 3.3 $ 23.4 (1) Excludes the non-cash costs of asset rationalizations ( $4.0 million ).
Restructuring and Related Costs [Table Text Block]	The following table details restructuring charges recorded during the three months ended March 31 : Three months ended In millions 2020 2019 Americas $ 20.8 $ 3.4 EMEA 0.6 0.5 Asia Pacific 1.1 1.3 Corporate and Other 3.1 0.9 Total $ 25.6 $ 6.1 Cost of goods sold $ 10.3 $ 3.4 Selling and administrative expenses 15.3 2.7 Total $ 25.6 $ 6.1

Other, Net (Tables)

Other, Net (Tables)	3 Months Ended
	Mar. 31, 2020
Other Net [Abstract]
Other, Net	The components of Other income/(expense), net for the three months ended March 31 are as follows: Three months ended In millions 2020 2019 Interest income/(loss) $ (0.1 ) $ (1.1 ) Exchange gain/(loss) (4.2 ) (4.3 ) Other components of net periodic benefit cost (1.7 ) (9.8 ) Other activity, net 18.5 (2.8 ) Other income/(expense), net $ 12.5 $ (18.0 )

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2020
Discontinued Operations [Abstract]
Summarized Financial Information For Discontinued Operations Text Block [Table Text Block]	The components of Discontinued operations, net of tax for the three months ended March 31 were as follows: In millions 2020 2019 Net revenues $ 469.8 $ 772.2 Cost of goods sold (315.8 ) (528.1 ) Selling and administrative expenses (1) (221.4 ) (162.1 ) Operating income (67.4 ) 82.0 Pre-tax earnings (loss) from discontinued operations (75.5 ) 79.4 Tax benefit (expense) (3.2 ) (23.0 ) Discontinued operations, net of tax $ (78.7 ) $ 56.4 (1) Includes pre-tax separation costs of $99.1 million ( $83.4 million net of tax), primarily related to legal, consulting and advisory fees, during the three months ended March 31, 2020.
Disposal groups, Ingersoll-Rand Industrial [Text Block]	Net revenues and earnings from operations, net of tax of Ingersoll Rand Industrial for the three months ended March 31 were as follows: Three months ended In millions 2020 2019 Net revenues $ 469.8 $ 772.2 Earnings (loss) attributable to Trane Technologies plc (1) (71.6 ) 57.8 Earnings (loss) attributable to noncontrolling interests 0.5 0.7 Earnings (loss) from operations, net of tax (1) $ (71.1 ) $ 58.5 (1) Includes pre-tax separation costs of $99.1 million ( $83.4 million net of tax), primarily related to legal, consulting and advisory fees, during the three months ended March 31, 2020.
Disclosure of Long Lived Assets Held-for-sale [Table Text Block]	The components of Discontinued operations, net of tax for the three months ended March 31 were as follows: In millions 2020 2019 Ingersoll Rand Industrial, net of tax $ (71.1 ) $ 58.5 Other discontinued operations, net of tax (7.6 ) (2.1 ) Discontinued operations, net of tax $ (78.7 ) $ 56.4
Disposal Groups, Assets and Liabilities Held-for-sale [Text Block]	The components of Ingersoll Rand Industrial's assets and liabilities recorded as held-for-sale on the Condensed Consolidated Balance Sheet at December 31, 2019 were as follows: In millions December 31, 2019 Assets Current assets (1) $ 1,130.6 Property, plant and equipment, net 454.3 Goodwill 1,657.4 Intangible assets, net 825.2 Other noncurrent assets 139.7 Assets held-for-sale $ 4,207.2 Liabilities Current liabilities $ 823.7 Noncurrent liabilities 376.7 Liabilities held-for-sale $ 1,200.4 (1) Includes $25 million cash and cash equivalents in accordance with the merger agreement.

Earnings Per Share (EPS) (Table

Earnings Per Share (EPS) (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share Basic and Diluted Shares	The following table summarizes the weighted-average number of ordinary shares outstanding for basic and diluted earnings per share calculations for the three months ended March 31 : Three months ended In millions, except per share amounts 2020 2019 Weighted-average number of basic shares 239.5 242.5 Shares issuable under incentive stock plans 2.8 2.7 Weighted-average number of diluted shares 242.3 245.2 Anti-dilutive shares 0.5 1.4 Dividends declared per ordinary share $ 0.53 $ 0.53

Business Segment Information (T

Business Segment Information (Tables)	3 Months Ended
	Mar. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Summary of Operations by Reportable Segments	A summary of operations by reportable segment for the three months ended March 31 was as follows: Three months ended In millions 2020 2019 Net revenues Americas $ 2,097.8 $ 2,144.3 EMEA 364.3 383.8 Asia Pacific 179.2 275.6 Total net revenues $ 2,641.3 $ 2,803.7 Segment adjusted EBITDA Americas $ 262.1 $ 297.8 EMEA 43.2 44.7 Asia Pacific 10.6 27.5 Total segment adjusted EBITDA $ 315.9 $ 370.0 Reconciliation of segment adjusted EBITDA to earnings before income taxes Total segment adjusted EBITDA $ 315.9 $ 370.0 Interest expense (63.1 ) (51.0 ) Depreciation and amortization (75.0 ) (70.9 ) Restructuring costs (25.6 ) (6.1 ) Unallocated corporate expenses (48.4 ) (74.5 ) Earnings before income taxes $ 103.8 $ 167.5

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2020
Schedule of Asbestos Related Balances	The Company’s liability for asbestos-related matters and the asset for probable asbestos-related insurance recoveries were included in the following balance sheet accounts: In millions March 31, December 31, Accrued expenses and other current liabilities $ 64.0 $ 63.0 Other noncurrent liabilities 468.6 484.4 Total asbestos-related liabilities $ 532.6 $ 547.4 Other current assets $ 48.7 $ 66.2 Other noncurrent assets 229.0 237.8 Total asset for probable asbestos-related insurance recoveries $ 277.7 $ 304.0
Cost Income Asbestos Related Claims After Recoveries	The net income (expense) associated with these transactions, for the three months ended March 31 , were as follows: Three months ended In millions 2020 2019 Continuing operations $ 15.6 $ (1.8 ) Discontinued operations (4.9 ) (3.0 ) Total $ 10.7 $ (4.8 )
Schedule of Product Warranty Liability [Table Text Block]	The changes in the standard product warranty liability for the three months ended March 31 were as follows: In millions 2020 2019 Balance at beginning of period $ 251.4 $ 245.6 Reductions for payments (32.7 ) (31.2 ) Accruals for warranties issued during the current period 30.1 33.5 Changes to accruals related to preexisting warranties (5.7 ) (1.0 ) Translation (0.9 ) (0.3 ) Balance at end of period $ 242.2 $ 246.6
Extended Warranty [Member]
Schedule of Product Warranty Liability [Table Text Block]	The changes in the extended warranty liability for the three months ended March 31 were as follows: In millions 2020 2019 Balance at beginning of period $ 302.8 $ 290.6 Amortization of deferred revenue for the period (28.8 ) (27.1 ) Additions for extended warranties issued during the period 30.9 28.4 Changes to accruals related to preexisting warranties (0.2 ) (0.2 ) Translation (0.9 ) — Balance at end of period $ 303.8 $ 291.7

Completion of Reverse Morris _2

Completion of Reverse Morris Trust Transaction (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Trust Transaction [Line Items]
Receipt of a one-time special cash payment	$ 1,900	$ 0

Inventories (Schedule of Major

Inventories (Schedule of Major Classes of Inventory) (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Inventory Valuation Reserves	$ 67.6	$ 66.1
Raw materials	348.8	333.5
Work-in-process	173.8	173.7
Finished goods	973.4	804.9
Sub-total	1,496	1,312.1
LIFO reserve	(32.3)	(33.5)
Total	$ 1,463.7	$ 1,278.6

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Goodwill [Roll Forward]
Accumulated Impairment	$ (2,496)	$ (2,496)
Currency translation	(43.4)
Goodwill (net)	5,082.3	5,125.7
EMEA [Member]
Goodwill [Roll Forward]
Currency translation	(24.3)
Goodwill (net)	706.8	731.1
Asia Pacific [Member]
Goodwill [Roll Forward]
Currency translation	(7)
Goodwill (net)	528.8	535.8
Americas [Member]
Goodwill [Roll Forward]
Currency translation	(12.1)
Goodwill (net)	$ 3,846.7	$ 3,858.8

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Finite-lived intangible assets, gross	$ 2,124.3		$ 2,140.7
Accumulated amortization	(1,460)		(1,442.6)
Net finite-lived intangible assets	664.3		698.1
Total intangible assets, gross	4,749		4,766.2
Intangible assets, net	3,289		3,323.6
Amortization of intangible assets	30.3	$ 29.1
Trademarks [Member]
Trademarks (indefinite-lived)	2,624.7		2,625.5
Customer Relationships [Member]
Finite-lived intangible assets, gross	1,919.6		1,928.5
Accumulated amortization	(1,262.9)		(1,239.2)
Net finite-lived intangible assets	656.7		689.3
Completed technologies/patents [Member]
Finite-lived intangible assets, gross	164.4		171.8
Accumulated amortization	(162.8)		(169.7)
Net finite-lived intangible assets	1.6		2.1
Other Intangible Assets [Member]
Finite-lived intangible assets, gross	40.3		40.4
Accumulated amortization	(34.3)		(33.7)
Net finite-lived intangible assets	$ 6		$ 6.7

Debt and Credit Facilities (Nar

Debt and Credit Facilities (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Feb. 29, 2016
Proceeds from long-term debt	$ 0	$ 1,497.9
Commercial Paper Program Maximum Aggregate Amount Available To Be Issued	2,000
Long-term debt excluding current maturities	4,624.8		$ 4,922.9
Short-term borrowings and current maturities of long-term debt	949.7		650.3
Debt Instrument, Fair Value Disclosure	5,900		6,200
Five Year Revolving Credit Facility Refinanced [Member]
Line of credit facility, amount outstanding	2,000
Five Year Revolving Credit Facility [Member]
Line of credit facility, amount outstanding	1,000
Commercial Paper [Member]
Short-term borrowings and current maturities of long-term debt			0
Debentures With Put Feature [Member]
Short-term borrowings and current maturities of long-term debt	$ 343		343
Debt Instrument, Maturity Date Range, Start	Jan. 1, 2027
Debt instrument, maturity date range, end	Jan. 1, 2028
Debentures with put option available to be exercised				$ 37.2
Three Point Five Percent Senior notes Due Two Thousand Twenty Six [Member]
Long-term debt excluding current maturities	$ 396.9	400	$ 396.8
Debt Instrument, Interest Rate, Stated Percentage	3.50%		3.50%
Three Point Eight Percent Senior Notes Due Two Thousand Twenty Nine [Member]
Long-term debt excluding current maturities	$ 743.7	750	$ 743.6
Debt Instrument, Interest Rate, Stated Percentage	3.80%		3.80%
Four Point Five Percent Senior Notes Due Two Thousand Forty Nine [Member]
Long-term debt excluding current maturities	$ 345.5	$ 350	$ 345.5
Debt Instrument, Interest Rate, Stated Percentage	4.50%		4.50%
4.25% Senior notes due 2023 [Member]
Long-term debt excluding current maturities	$ 697.9		$ 697.8
Debt Instrument, Interest Rate, Stated Percentage	4.25%		4.25%
5.75% Senior notes due 2043 [Member]
Long-term debt excluding current maturities	$ 494.6		$ 494.5
Debt Instrument, Interest Rate, Stated Percentage	5.75%		5.75%
Three Point Five Five Percent Senior Notes due 2024 [Member]
Long-term debt excluding current maturities	$ 496.8		$ 496.6
Debt Instrument, Interest Rate, Stated Percentage	3.55%		3.55%
Four Point Six Five Percent Senior Notes due Twenty Forty Four [Member]
Long-term debt excluding current maturities	$ 296		$ 295.9
Debt Instrument, Interest Rate, Stated Percentage	4.65%		4.65%

Debt and Credit Facilities (Sho

Debt and Credit Facilities (Short-Term Borrowings and Current Maturities of Long-Term Debt) (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Short-term borrowings and current maturities of long-term debt	$ 949.7	$ 650.3
Debentures With Put Feature [Member]
Short-term borrowings and current maturities of long-term debt	343	343
Two Point Six Two Five Percent Senior Notes Due Two Thousand Twenty [Member]
Short-term borrowings and current maturities of long-term debt	299.9	299.8
Commercial Paper [Member]
Short-term borrowings and current maturities of long-term debt		0
Current Maturities Of Long Term Debt [Member]
Short-term borrowings and current maturities of long-term debt	7.5	7.5
Two Point Nine Percent Senior Notes Due Two Thousand Twenty One [Member] [Member]
Short-term borrowings and current maturities of long-term debt	$ 299.3	$ 0

Debt and Credit Facilities (Lon

Debt and Credit Facilities (Long-Term Debt Excluding Current Maturities) (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Long-term debt excluding current maturities	$ 4,624.8	$ 4,922.9
Two Point Nine Percent Senior Notes Due Two Thousand Twenty One [Member] [Member]
Debt Instrument, Interest Rate, Stated Percentage		2.90%
Long-term debt excluding current maturities	$ 0	$ 299.1
9.00% Debentures Due 2021 [Member]
Debt Instrument, Interest Rate, Stated Percentage	9.00%	9.00%
Long-term debt excluding current maturities	$ 124.9	$ 124.9
4.25% Senior notes due 2023 [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.25%	4.25%
Long-term debt excluding current maturities	$ 697.9	$ 697.8
Seven Point Two Zero Percent Debentures [Domain]
Long-term debt excluding current maturities	$ 37.3	$ 37.3
Three Point Five Five Percent Senior Notes due 2024 [Member]
Debt Instrument, Interest Rate, Stated Percentage	3.55%	3.55%
Long-term debt excluding current maturities	$ 496.8	$ 496.6
6.48% Debentures Due 2025 [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.48%	6.48%
Long-term debt excluding current maturities	$ 149.7	$ 149.7
Three Point Five Percent Senior notes Due Two Thousand Twenty Six [Member]
Debt Instrument, Interest Rate, Stated Percentage	3.50%	3.50%
Long-term debt excluding current maturities	$ 396.9	$ 396.8	$ 400
Three Point Seven Five Percent Senior Notes Due Two Thousand Twenty Eight [Member]
Debt Instrument, Interest Rate, Stated Percentage	3.75%	3.75%
Long-term debt excluding current maturities	$ 545.2	$ 545.1
Three Point Eight Percent Senior Notes Due Two Thousand Twenty Nine [Member]
Debt Instrument, Interest Rate, Stated Percentage	3.80%	3.80%
Long-term debt excluding current maturities	$ 743.7	$ 743.6	750
5.75% Senior notes due 2043 [Member]
Debt Instrument, Interest Rate, Stated Percentage	5.75%	5.75%
Long-term debt excluding current maturities	$ 494.6	$ 494.5
Four Point Six Five Percent Senior Notes due Twenty Forty Four [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.65%	4.65%
Long-term debt excluding current maturities	$ 296	$ 295.9
Seven Point Two Zero Percent Debentures due Two Thousand Fourteen to Two Thousand Twenty Five [Member] [Member]
Debt Instrument, Interest Rate, Stated Percentage	7.20%	7.20%
Four Point Three Percent Senior Notes Due Two Thousand Forty Eight [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.30%	4.30%
Long-term debt excluding current maturities	$ 296	$ 296
Four Point Five Percent Senior Notes Due Two Thousand Forty Nine [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.50%	4.50%
Long-term debt excluding current maturities	$ 345.5	$ 345.5	$ 350
Other Loans and Notes [Member]
Long-term debt excluding current maturities	$ 0.3	$ 0.1

Financial Instruments (Narrativ

Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2014	Dec. 31, 2019	Dec. 31, 2018
Deferred gain/loss, net of tax, included in accumulated other comprehensive income (AOCI) related to the fair value of the Company's currency derivatives designated as accounting hedges	$ (926)	$ (958.6)		$ (1,006.6)	$ (964.1)
Amount expected to be reclassified into interest expense over the next twelve months	0.7
Foreign Exchange Contract [Member]
Derivative, Notional Amount	500
Currency derivatives expected to be reclassified into earnings over the next twelve months	1.3
Interest Rate Swap [Member]
Derivative, Notional Amount	1,300
Designated as Hedging Instrument [Member]
Deferred (loss) remaining in AOCI related to the interest rate locks	0	$ 0
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Deferred gain/loss, net of tax, included in accumulated other comprehensive income (AOCI) related to the fair value of the Company's currency derivatives designated as accounting hedges	2.7			$ 2.9
Senior Notes Issued in 2013 [Member] | Interest Rate Swap [Member]
Deferred (loss) remaining in AOCI related to the interest rate locks	$ 5.8		$ 6

Financial Instruments Schedule

Financial Instruments Schedule of the Fair Values of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Derivatives, Fair Value [Line Items]
Derivative asset fair value	$ 6.4	$ 1.1
Derivative liability fair value	6	7.2
Significant Other Observable Inputs (Level 2) [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	6.4	1.1
Derivative liability fair value	6	7.2
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	0.6	0.1
Derivative liability fair value	4.2	3.9
Foreign Exchange Contract [Member] | Nondesignated [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	5.8	1
Derivative liability fair value	$ 1.8	$ 3.3

Financial Instruments Schedul_2

Financial Instruments Schedule of Derivatives Designated as Hedges Affecting Condensed Consolidated Income Statement and Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Cost of Goods and Services Sold	$ 1,898.8	$ 1,989.2
Interest Expense	63.1	51
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax	0.3	(1.4)
Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)	0	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(0.3)	(0.1)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0.3	(1.4)
Designated as Hedging Instrument [Member] | cost of goods sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net	(0.5)	(0.3)
Gain (Loss) on Foreign Currency Cash Flow Hedge Ineffectiveness	(0.6)	(0.6)
Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net		$ 0.2
Designated as Hedging Instrument [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net	$ 0.2

Financial Instruments Schedul_3

Financial Instruments Schedule of Gains and Losses of Derivative Financial Instruments Not Designated as Hedges (Details) - Other Income [Member] - Nondesignated [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments	$ 8.3	$ (3)
Derivative, Gain (Loss) on Derivative, Net	$ 8.3	$ (3)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 6.4	$ 1.1
Derivative Liability, Fair Value, Gross Liability	6	7.2
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	6.4	1.1
Derivative Liability, Fair Value, Gross Liability	6	7.2
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	$ 0	$ 0

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Jan. 01, 2020
Leases [Abstract]
Prepaid lease payments and lease incentives	$ 5.6	$ 5.5

Leases - Summary of Company's L

Leases - Summary of Company's Lease Portfolio and Balance Sheet Components (Details) - USD ($) $ in Millions	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease right-of-use assets	$ 453.7	$ 469.4
Operating lease current	143.4	145
Operating lease noncurrent	$ 315.9	$ 329.9
Operating Lease, Weighted Average Remaining Lease Term	4 years 3 months 18 days		4 years 3 months 18 days
Operating Lease, Weighted Average Discount Rate, Percent	3.50%		3.60%

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Cost and Related Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease expense	$ 42.9	$ 38.7
Variable lease expense	6.2	6.4
Operating cash flows from operating leases	42.7	38.3
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 43.5	$ 38.5

Leases - Maturities of Lease Ob

Leases - Maturities of Lease Obligations (Details) $ in Millions	Mar. 31, 2020USD ($)
Leases [Abstract]
Remaining nine months of 2020	$ 121.1
2020	130.2
2021	93.2
2022	64.3
2023	37.5
After 2024	51.6
Total lease payments	497.9
Less: Interest	(38.6)
Present value of lease liabilities	$ 459.3

Pensions and Postretirement B_3

Pensions and Postretirement Benefits Other than Pensions (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Company contributions	$ 50	$ 18.6
Distribution of Industrial Businesses	(1,334.3)
Pension Costs [Member]
Defined Benefit Plan, Benefit Obligation, Divestiture	488.7
Defined Benefit Plan, Plan Assets, Divestiture	351.3
Actuarial gain (loss)	(11.3)	(13.4)
Pension Plan, Defined Benefit [Member]
Expected future employer contributions in 2017	91
Postretirement Benefit Costs [Member]
Defined Benefit Plan, Benefit Obligation, Divestiture	29.8
Actuarial gain (loss)	1.1	$ 1.6
Reverse Morris Trust Transaction [Member]
Company contributions	24.4
Accumulated Defined Benefit Plans Adjustment [Member]
Distribution of Industrial Businesses	69.1
Accumulated Defined Benefit Plans Adjustment [Member] | Pension Costs [Member]
Distribution of Industrial Businesses	114.2
Accumulated Defined Benefit Plans Adjustment [Member] | Postretirement Benefit Costs [Member]
Distribution of Industrial Businesses	$ 4.1

Pensions and Postretirement B_4

Pensions and Postretirement Benefits Other than Pensions (Components of the Company's Pension-Related Costs) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Total	$ (1.7)	$ (9.8)
Pension Costs [Member]
Service cost	17.7	18.1
Interest cost	22.5	29.8
Expected return on plan assets	(31.9)	(34.6)
Net amortization of prior service costs	1.3	1.2
Net amortization of plan net actuarial losses	11.3	13.4
Net periodic pension benefit cost	20.9	27.9
Net curtailment loss	3.6	(1.6)
Total	17.3	29.5
Pension Costs [Member] | Continuing Operations [Member]
Total
Pension Costs [Member] | Discontinued Operations [Member]
Total	1.8	6.9
Operating Income (Loss) [Member] | Pension Costs [Member] | Continuing Operations [Member]
Total	14.8	14.3
Other Nonoperating Income (Expense) [Member] | Pension Costs [Member] | Continuing Operations [Member]
Total	$ 0.7	$ 8.3

Pensions and Postretirement B_5

Pensions and Postretirement Benefits Other than Pensions (Components of Net Periodic Postretirement Benefit Cost) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Total	$ (1.7)	$ (9.8)
Postretirement Benefit Costs [Member]
Defined Benefit Plan, Benefit Obligation, Divestiture	29.8
Service cost	0.6	0.6
Interest cost	2.6	3.9
Net amortization of prior service gains	0	(0.1)
Net amortization of plan net actuarial losses	(1.1)	(1.6)
Total	2.1	2.8
Postretirement Benefit Costs [Member] | Continuing Operations [Member]
Total
Postretirement Benefit Costs [Member] | Discontinued Operations [Member]
Total	0.5	0.7
Operating Income (Loss) [Member] | Postretirement Benefit Costs [Member] | Continuing Operations [Member]
Total	0.6	0.6
Other Nonoperating Income (Expense) [Member] | Postretirement Benefit Costs [Member] | Continuing Operations [Member]
Total	$ 1	$ 1.5

Equity (Reconciliation of Ordin

Equity (Reconciliation of Ordinary Shares) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock Repurchased During Period, Value	$ 0
Ordinary shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (shares)	262.8	266.4
Shares issued under incentive plans, net	0.9
Repurchase of ordinary shares (shares)		(2.4)
Ending balance (shares)	263.7	265.5
Ordinary shares held in treasury, at cost
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (shares)	24.5
Shares issued under incentive plans, net	0
Ending balance (shares)	24.5

Equity (Components of Sharehold

Equity (Components of Shareholders' Equity) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Payments for Repurchase of Common Stock	$ 0	$ 250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	7,312.4	7,064.8
Net earnings	(25.9)	203.7
Total comprehensive income (loss)	(84.5)	209.6
Share-based compensation	27.6	29
Dividends declared to noncontrolling interests	(6.1)	(9.3)
Shares issued under incentive plans, net		(6.3)
Repurchase of ordinary shares		(250)
Ending balance	5,789.8	6,922.8
Other		(0.1)
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	44.8	42.1
Net earnings	3.3	3.8
Dividends declared to noncontrolling interests	(6.1)	(9.3)
Ending balance	$ 17.2	$ 37

Equity Equity (Changes in Accum

Equity Equity (Changes in Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at December 31:	$ (1,006.6)	$ (964.1)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(67.5)	(3.5)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	11.8	13
Provision for income taxes	(3)	(4)
Other comprehensive income (loss)	(58.6)	5.9
Balance at June 30:	(926)	(958.6)
Distribution of Industrial Businesses	(1,334.3)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at December 31:	(554.8)	(516.8)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(48.1)	(2.4)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0
Provision for income taxes	0	0
Other comprehensive income (loss)	22.1	(2.4)
Balance at June 30:	(532.7)	(519.2)
Distribution of Industrial Businesses	70.2
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss)	(58.7)	5.5
Distribution of Industrial Businesses	139.3
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at December 31:	5.6	6.7
Other Comprehensive Income (Loss), before Reclassifications, before Tax	0.3	(1.4)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0.3	0.1
Provision for income taxes	(0.2)	(0.5)
Other comprehensive income (loss)	0.4	(1.8)
Balance at June 30:	6	4.9
Distribution of Industrial Businesses	0
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at December 31:	(457.4)	(454)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(19.7)	0.3
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	11.5	12.9
Provision for income taxes	(2.8)	(3.5)
Other comprehensive income (loss)	58.1	9.7
Balance at June 30:	(399.3)	$ (444.3)
Distribution of Industrial Businesses	69.1
IndustrialSegmentBusinesses [Domain] | Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss)	$ 80.6

Equity Equity (Narrative) (Deta

Equity Equity (Narrative) (Details) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Mar. 31, 2020€ / shares	Mar. 31, 2020USD ($)$ / sharesshares	Mar. 31, 2018USD ($)
Common Stock, Par or Stated Value Per Share | $ / shares				$ 1
Preferred Stock, Par or Stated Value Per Share | $ / shares				$ 0.001
Capital Units, Authorized | shares				1,185,040,000
Stock Repurchase Program, Authorized Amount | $					$ 1,500
Stock Repurchased During Period, Value | $	$ 0
Repurchase of ordinary shares | $	$ 0	$ (250)
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $				$ 750
Preferred Stock [Member]
Preferred Stock, Shares Authorized | shares				10,000,000
Ordinary shares
Common Stock, Shares Authorized | shares				1,175,000,000
Euro Member Countries, Euro
Common Stock, Shares Authorized | shares				40,000
Common Stock, Par or Stated Value Per Share | € / shares			€ 1

Revenue (Details)

Revenue (Details)	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	37.00%
Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	81.00%	83.00%

Revenue - Desegregation of Reve

Revenue - Desegregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Net revenues	$ 2,641.3	$ 2,803.7
Americas [Member]
Disaggregation of Revenue [Line Items]
Net revenues	2,097.8	2,144.3
Americas [Member] | Equipment
Disaggregation of Revenue [Line Items]
Net revenues	1,392.6	1,483.2
Americas [Member] | Services and parts
Disaggregation of Revenue [Line Items]
Net revenues	705.2	661.1
EMEA [Member]
Disaggregation of Revenue [Line Items]
Net revenues	364.3	383.8
EMEA [Member] | Equipment
Disaggregation of Revenue [Line Items]
Net revenues	248.8	262.3
EMEA [Member] | Services and parts
Disaggregation of Revenue [Line Items]
Net revenues	115.5	121.5
Asia Pacific [Member]
Disaggregation of Revenue [Line Items]
Net revenues	179.2	275.6
Asia Pacific [Member] | Equipment
Disaggregation of Revenue [Line Items]
Net revenues	111	192.8
Asia Pacific [Member] | Services and parts
Disaggregation of Revenue [Line Items]
Net revenues	$ 68.2	$ 82.8

Revenue - Schedule of Assets an

Revenue - Schedule of Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Contract assets	$ 204.5	$ 172.6
Contract liabilities	$ 979.4	$ 941.9

Revenue Schedule of impact of a

Revenue Schedule of impact of adopting ASC 606 on the Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Net revenues	$ 2,641.3	$ 2,803.7
Cost of goods sold	(1,898.8)	(1,989.2)
Selling and administrative expenses	(588.1)	(578)
Operating income	154.4	236.5
Interest expense	(63.1)	(51)
Other income/(expense), net	(12.5)	18
Earnings before income taxes	103.8	167.5
Benefit (provision) for income taxes	(51)	(20.2)
Earnings from continuing operations	$ 52.8	$ 147.3

Revenue - Contract liability ba

Revenue - Contract liability balances to be recognized (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Contract with Customer, Liability, Revenue Recognized	$ 0.29
Contract liabilities	$ 979,400,000	$ 941,900,000
Remaining performance obligation, percentage	37.00%

Share-Based Compensation (Narra

Share-Based Compensation (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost	$ 0.1
Share based compensation expense	28.1	$ 31.5
Share based compensation expense, net of tax	$ 21.3	23.9
Percentage Of Awards Applied To Performance Condition	50.00%
Percentage of Awards Applied to Market Condition	50.00%
Stock options and Restricted Stock Units (RSUs) [Member]
Vesting period, in years	3 years
Share-based Payment Arrangement, Option [Member]
Share based compensation expense	$ 9.7	$ 11.8
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	189,546	242,104
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	1,020,535	1,259,344

Share-Based Compensation (Share

Share-Based Compensation (Share-Based Compensation Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share based compensation expense	$ 28.1	$ 31.5
Tax benefit	(6.8)	(7.6)
After-tax expense	21.3	23.9
Stock Options [Member]
Share based compensation expense	9.7	11.8
Restricted Stock Units (RSUs) [Member]
Share based compensation expense	11	13
Performance Shares [Member]
Share based compensation expense	7.8	4.4
Deferred Compensation [Member]
Share based compensation expense	1.4	0.9
Other share based compensation [Member]
Share based compensation expense	(1.8)	1.4
Continuing Operations [Member]
After-tax expense	20.3	21.2
Discontinued Operations [Member]
After-tax expense	$ 1	$ 2.7

Share-Based Compensation (Grant

Share-Based Compensation (Grants of Stock Options and RSUs) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock Options [Member]
Equity awards, granted, in shares	1,020,535	1,259,344
Weighted average fair value per award, in dollars per share	$ 16.75	$ 17.09
RSUs [Member]
Equity awards, granted, in shares	189,546	242,104
Weighted average fair value per award, in dollars per share	$ 104.80	$ 100.70
Phantom Share Units (PSUs) [Member]
Equity awards, granted, in shares	259,920	306,352
Weighted average fair value per award, in dollars per share	$ 141.88	$ 110.57

Share-Based Compensation Share-

Share-Based Compensation Share-Based Compensation (Average Fair Value of Stock Options Granted, Assumptions) (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Dividend yield	2.01%	2.09%
Volatility	24.33%	21.46%
Risk-free rate of return	0.56%	2.49%
Expected life, in years	4 years 9 months 18 days	4 years 9 months 18 days

Restructuring Costs (Details)

Restructuring Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Settled without Cash	$ 4
Restructuring Reserve, Current	23.4		$ 25.4
Restructuring and Related Cost, Incurred Cost	25.6	$ 6.1
Restructuring and Related Cost, Incurred Cost excluding asset realization	21.6
Payments for Restructuring	(23.6)
cost of goods sold [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	10.3	3.4
selling and administrative expenses [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	15.3	2.7
Americas [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Current	16.8		11.9
Restructuring and Related Cost, Incurred Cost	20.8	3.4
Restructuring and Related Cost, Incurred Cost excluding asset realization	16.8
Payments for Restructuring	11.9
EMEA [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Current	2.2		2.8
Restructuring and Related Cost, Incurred Cost	0.6	0.5
Restructuring and Related Cost, Incurred Cost excluding asset realization	0.6
Payments for Restructuring	1.2
Asia Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Current	1.1		9.1
Restructuring and Related Cost, Incurred Cost	1.1	1.3
Restructuring and Related Cost, Incurred Cost excluding asset realization	1.1
Payments for Restructuring	9.1
Corporate and Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Current	3.3		$ 1.6
Restructuring and Related Cost, Incurred Cost	3.1	$ 0.9
Restructuring and Related Cost, Incurred Cost excluding asset realization	3.1
Payments for Restructuring	$ 1.4

Restructuring Costs Non-qualifi

Restructuring Costs Non-qualified restructuring charges incurred (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)
Restructuring and Related Activities [Abstract]
Restructuring Reserve, Settled without Cash	$ 4

Other, Net (Details)

Other, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Legacy Legal Liability Overstatement	$ 17.4
Interest Income, Other	(0.1)	$ (1.1)
Exchange gain (loss)	4.2	4.3
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	(1.7)	(9.8)
Other	18.5	(2.8)
Other, net	$ 12.5	$ (18)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Unrecognized Tax Benefits	$ 63.7		$ 63.5
Effective Tax Rate Year-to-date	4910.00%	1210.00%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 37

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	$ (79.2)	$ 55.7
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest	(0.5)	(0.7)
Discontinued operations, net of tax	(78.7)	56.4
Disposal Group, Including Discontinued Operation, Assets, Current			$ 1,130.6
Disposal Group, Including Discontinued Operation, Revenue	469.8	772.2
Disposal Group, Including Discontinued Operation, Costs of Goods Sold	(315.8)	(528.1)
Disposal Group, Including Discontinued Operation, General and Administrative Expense	(221.4)	(162.1)
Disposal Group, Including Discontinued Operation, Operating Income (Loss)	(67.4)	82
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	(75.5)	79.4
Discontinued Operation, Tax Effect of Discontinued Operation	3.2	23
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent			454.3
Disposal Group, Including Discontinued Operation, Goodwill			1,657.4
Disposal Group, Including Discontinued Operation, Intangible Assets			825.2
Disposal Group, Including Discontinued Operation, Assets, Noncurrent			139.7
Disposal Group, Including Discontinued Operation, Assets	0		4,207.2
Disposal Group, Including Discontinued Operation, Liabilities, Current			823.7
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent			376.7
Disposal Group, Including Discontinued Operation, Liabilities	0		1,200.4
IndustrialSegmentBusinesses [Domain]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation costs	99.1
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	(71.6)	57.8
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest	0.5	0.7
Discontinued operations, net of tax	(71.1)	58.5
Separation costs, net of tax	83.4
Cash and Cash Equivalents [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Assets, Current			$ 25
Other Discontinued Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations, net of tax	$ (7.6)	$ (2.1)

Earnings Per Share (EPS) (Detai

Earnings Per Share (EPS) (Details) - $ / shares shares in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Weighted-average number of basic shares	239.5	242.5
Shares issuable under incentive stock plans	2.8	2.7
Weighted average number of diluted shares	242.3	245.2
Anti-dilutive shares	0.5	1.4
Dividends declared per ordinary share	$ 0.53	$ 0.53

Business Segment Information (S

Business Segment Information (Summary of Operations by Reportable Segments) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net revenues	$ 2,641.3	$ 2,803.7
Segment Adjusted EBITDA	315.9	370
Unallocated corporate expense	48.4	74.5
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	103.8	167.5
Operating income	154.4	236.5
Interest Expense	(63.1)	(51)
Income Tax Expense (Benefit)	(51)	(20.2)
Depreciation	(75)	(70.9)
Restructuring and Related Cost, Incurred Cost	(25.6)	(6.1)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	52.8	147.3
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(78.7)	56.4
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(25.9)	203.7
Americas [Member]
Net revenues	2,097.8	2,144.3
Segment Adjusted EBITDA	262.1	297.8
Restructuring and Related Cost, Incurred Cost	(20.8)	(3.4)
EMEA [Member]
Net revenues	364.3	383.8
Segment Adjusted EBITDA	43.2	44.7
Restructuring and Related Cost, Incurred Cost	(0.6)	(0.5)
Asia Pacific [Member]
Net revenues	179.2	275.6
Segment Adjusted EBITDA	10.6	27.5
Restructuring and Related Cost, Incurred Cost	$ (1.1)	$ (1.3)

Commitments and Contingencies_2

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Reserves for environmental matters	$ 40.4	$ 40.2
Percentage of non-malignant claims, minimum	73.00%	73.00%
Total current standard product warranty reserve	$ 118.8	$ 124.9
Total current extended warranty liability	$ 107.1	107.3
Expected annual inflation rate	2.50%
Adjusted Expected Annual Inflation Rate	1.00%
Discontinued Operations [Member]
Reserves for environmental matters	$ 37.8	37.5
Asbestos [Member]
Total Asset For Probable Asbestos Related Insurance Recoveries	277.7	304
Asbestos [Member] | IR New Jersey [Member]
Total Asset For Probable Asbestos Related Insurance Recoveries	166.6	188.7
Asbestos [Member] | Trane [Member]
Total Asset For Probable Asbestos Related Insurance Recoveries	$ 111.1	$ 115.3

Commitments and Contingencies_3

Commitments and Contingencies (Schedule of Asbestos-Related Balances) (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Accrued expenses and other current liabilities	$ 1,528.4	$ 1,564.2
Other noncurrent liabilities	1,410.8	1,398.2
Other current assets	356.6	344.8
Other noncurrent assets	1,378.3	1,397.2
Asbestos [Member]
Accrued expenses and other current liabilities	64	63
Other noncurrent liabilities	468.6	484.4
Total asbestos-related liabilities	532.6	547.4
Other current assets	48.7	66.2
Other noncurrent assets	229	237.8
Total asset for probable asbestos-related insurance recoveries	277.7	304
IR New Jersey [Member] | Asbestos [Member]
Total asset for probable asbestos-related insurance recoveries	166.6	188.7
Trane [Member] | Asbestos [Member]
Total asset for probable asbestos-related insurance recoveries	$ 111.1	$ 115.3

Commitments and Contingencies_4

Commitments and Contingencies (Cost/Income Asbestos Related Claims after Recoveries) (Details) - Asbestos [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Continuing operations	$ 15.6	$ (1.8)
Discontinued operations	(4.9)	(3)
Total	$ 10.7	$ (4.8)

Commitments and Contingencies_5

Commitments and Contingencies (Product Warranty Liability) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Balance at beginning of period	$ 251.4	$ 245.6
Reductions for payments	(32.7)	(31.2)
Accruals for warranties issued during the current period	30.1	33.5
Changes to accruals related to preexisting warranties	(5.7)	(1)
Translation	(0.9)	(0.3)
Balance at end of period	$ 242.2	$ 246.6

Commitments and Contingencies C

Commitments and Contingencies Commitments and Contingencies (Extended Warranty Accrual) (Details) - Extended Warranty [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Balance at beginning of period	$ 302.8	$ 290.6
Amortization of deferred revenue for the period	(28.8)	(27.1)
Additions for extended warranties issued during the period	30.9	28.4
Changes to accruals related to preexisting warranties	(0.2)	(0.2)
Translation	(0.9)	0
Balance at end of period	$ 303.8	$ 291.7